<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">RNHbRVknnxZXkDsYMFvkSCD</article-id>
      <article-id pub-id-type="other">00006</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2009001000006</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(09)09300406</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2009001000006</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigos Originais</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Escore de risco Dante Pazzanese para s&#237;ndrome coronariana aguda sem supradesnivelamento do segmento ST</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Santos</surname>
            <given-names>Elizabete Silva dos</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Timerman</surname>
            <given-names>Ari</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Baltar</surname>
            <given-names>Val&#233;ria Troncoso</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Castillo</surname>
            <given-names>Maria Tereza Cabrera</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pereira</surname>
            <given-names>Marcos Paulo</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Minuzzo</surname>
            <given-names>Luiz</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Piegas</surname>
            <given-names>Leopoldo Soares</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
      </contrib-group>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="city">S&#227;o Paulo</named-content>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade de S&#227;o Paulo</institution>
        <institution content-type="orgdiv1">FM </institution>
        <institution content-type="orgdiv2">HC</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff02">
        <addr-line>
          <named-content content-type="city">S&#227;o Paulo</named-content>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Instituto Dante Pazzanese de Cardiologia</institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>10</month>
        <year>2009</year>
      </pub-date>
      <volume>93</volume>
      <issue>4</issue>
      <fpage>343</fpage>
      <lpage>351</lpage>
      <history>
        <date date-type="accepted">
          <day>18</day>
          <month>03</month>
          <year>2009</year>
        </date>
        <date date-type="rev-recd">
          <day>18</day>
          <month>03</month>
          <year>2009</year>
        </date>
        <date date-type="received">
          <day>25</day>
          <month>11</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>FUNDAMENTO: Em s&#237;ndrome coronariana aguda (SCA), &#233; importante estimar a probabilidade de eventos adversos. OBJETIVO: Desenvolver um escore de risco em uma popula&#231;&#227;o brasileira com SCA sem supradesnivelamento do segmento ST (SST). M&#201;TODOS: Foram avaliados prospectivamente 1.027 pacientes em um centro brasileiro de cardiologia. Um modelo de regress&#227;o log&#237;stica m&#250;ltipla foi desenvolvido para prever o risco de morte ou de (re)infarto em 30 dias. A acur&#225;cia preditiva do modelo foi determinada pelo C statistic. RESULTADOS: O evento combinado ocorreu em 54 pacientes (5,3%). O escore foi criado pela soma aritm&#233;tica de pontos dos preditores independentes, cujas pontua&#231;&#245;es foram designadas pelas respectivas probabilidades de ocorr&#234;ncia do evento. As seguintes vari&#225;veis foram identificadas: aumento da idade (0 a 9 pontos); antecedente de diabete melito (2 pontos) ou de acidente vascular cerebral (4 pontos); n&#227;o utiliza&#231;&#227;o pr&#233;via de inibidor da enzima conversora da angiotensina (1 ponto); eleva&#231;&#227;o da creatinina (0 a 10 pontos); e combina&#231;&#227;o de eleva&#231;&#227;o da troponina I card&#237;aca e depress&#227;o do segmento ST (0 a 4 pontos). Foram definidos quatro grupos de risco: muito baixo (at&#233; 5 pontos); baixo (6 a 10 pontos); intermedi&#225;rio (11 a 15 pontos); e alto risco (16 a 30 pontos). O C statistic para a probabilidade do evento foi de 0,78 e para o escore de risco em pontua&#231;&#227;o de 0,74. CONCLUS&#195;O: Um escore de risco foi desenvolvido para prever morte ou (re)infarto em 30 dias em uma popula&#231;&#227;o brasileira com SCA sem SST, podendo facilmente ser aplic&#225;vel no departamento de emerg&#234;ncia.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>Doen&#231;as cardiovasculares</kwd>
        <kwd>angina inst&#225;vel</kwd>
        <kwd>infarto do mioc&#225;rdio</kwd>
        <kwd>progn&#243;stico</kwd>
        <kwd>fatores de risco</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>24</day>
        <month>11</month>
        <year>2009</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>ARTIGO ORIGINAL </p>
    <p> CARDIOGERIATRIA</p>
    <p>
      <bold>Escore de risco Dante Pazzanese para s&#237;ndrome coronariana aguda sem supradesnivelamento do segmento ST</bold>
    </p>
    <p>
      <bold>Elizabete Silva dos Santos<sup>I, II</sup>; Ari Timerman<sup>II</sup>; Val&#233;ria Troncoso Baltar<sup>II</sup>; Maria Tereza Cabrera Castillo<sup>II</sup>; Marcos Paulo Pereira<sup>II</sup>; Luiz Minuzzo<sup>II</sup>; Leopoldo Soares Piegas<sup>II</sup></bold>
    </p>
    <p><sup>I</sup>Instituto do Cora&#231;&#227;o (InCor) HC-FMUSP, S&#227;o Paulo, SP, Brasil </p>
    <p><sup>II</sup>Instituto Dante Pazzanese de Cardiologia, S&#227;o Paulo, SP, Brasil</p>
    <p>
      <xref ref-type="corresp" rid="back">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p><bold>FUNDAMENTO: </bold> Em s&#237;ndrome coronariana aguda (SCA), &#233; importante estimar a probabilidade de eventos adversos. </p>
    <p><bold>OBJETIVO:</bold> Desenvolver um escore de risco em uma popula&#231;&#227;o brasileira com SCA sem supradesnivelamento do segmento ST (SST). </p>
    <p><bold>M&#201;TODOS:</bold> Foram avaliados prospectivamente 1.027 pacientes em um centro brasileiro de cardiologia. Um modelo de regress&#227;o log&#237;stica m&#250;ltipla foi desenvolvido para prever o risco de morte ou de (re)infarto em 30 dias. A acur&#225;cia preditiva do modelo foi determinada pelo <italic>C statistic</italic>. </p>
    <p><bold>RESULTADOS:</bold> O evento combinado ocorreu em 54 pacientes (5,3%). O escore foi criado pela soma aritm&#233;tica de pontos dos preditores independentes, cujas pontua&#231;&#245;es foram designadas pelas respectivas probabilidades de ocorr&#234;ncia do evento. As seguintes vari&#225;veis foram identificadas: aumento da idade (0 a 9 pontos); antecedente de diabete melito (2 pontos) ou de acidente vascular cerebral (4 pontos); n&#227;o utiliza&#231;&#227;o pr&#233;via de inibidor da enzima conversora da angiotensina (1 ponto); eleva&#231;&#227;o da creatinina (0 a 10 pontos); e combina&#231;&#227;o de eleva&#231;&#227;o da troponina I card&#237;aca e depress&#227;o do segmento ST (0 a 4 pontos). Foram definidos quatro grupos de risco: muito baixo (at&#233; 5 pontos); baixo (6 a 10 pontos); intermedi&#225;rio (11 a 15 pontos); e alto risco (16 a 30 pontos). O <italic>C statistic</italic> para a probabilidade do evento foi de 0,78 e para o escore de risco em pontua&#231;&#227;o de 0,74. </p>
    <p><bold>CONCLUS&#195;O: </bold> Um escore de risco foi desenvolvido para prever morte ou (re)infarto em 30 dias em uma popula&#231;&#227;o brasileira com SCA sem SST, podendo facilmente ser aplic&#225;vel no departamento de emerg&#234;ncia.</p>
    <p><bold>Palavras-chave: </bold> Doen&#231;as cardiovasculares, angina inst&#225;vel, infarto do mioc&#225;rdio, progn&#243;stico, fatores de risco.</p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>As doen&#231;as cardiovasculares representam a primeira causa de morte n&#227;o s&#243; nos pa&#237;ses desenvolvidos, mas tamb&#233;m nos em desenvolvimento<sup>1</sup>.</p>
    <p>O risco de &#243;bito ou de eventos isqu&#234;micos recorrentes entre pacientes com s&#237;ndrome coronariana aguda (SCA) sem supradesnivelamento do segmento ST (SST) varia amplamente devido &#224; sua natureza heterog&#234;nea. Determinar o risco da ocorr&#234;ncia desses eventos &#233; importante para a triagem inicial no departamento de emerg&#234;ncia, onde ser&#227;o identificados os pacientes que se beneficiam de condutas mais agressivas, dispendiosas e de maior morbidade e mortalidade<sup>2</sup>. &#201; importante determinar tal risco para que se fa&#231;a a escolha do local mais apropriado para realiza&#231;&#227;o dos cuidados m&#233;dicos e na indica&#231;&#227;o da estrat&#233;gia invasiva precoce<sup>3</sup>. A decis&#227;o de qual terapia utilizar para cada paciente depende da apresenta&#231;&#227;o cl&#237;nica e dos benef&#237;cios alcan&#231;ados com o tratamento institu&#237;do<sup>4</sup>, os quais devem compensar os riscos de resultados adversos.</p>
    <p>A estrat&#233;gia para estratifica&#231;&#227;o de risco objetiva uma avalia&#231;&#227;o de vari&#225;veis que possa prever resultados adversos no momento da admiss&#227;o no departamento de emerg&#234;ncia<sup>5</sup>. Deve ser baseada na combina&#231;&#227;o da hist&#243;ria cl&#237;nica, sintomas apresentados, altera&#231;&#245;es eletrocardiogr&#225;ficas, biomarcadores plasm&#225;ticos e resultados dos escores de risco<sup>6</sup>.</p>
    <p>O objetivo desta pesquisa foi desenvolver um modelo simples de estratifica&#231;&#227;o de risco, facilmente aplic&#225;vel no departamento de emerg&#234;ncia, em uma popula&#231;&#227;o brasileira n&#227;o selecionada, com o uso de vari&#225;veis cl&#237;nicas, eletrocardiogr&#225;ficas e biomarcadores plasm&#225;ticos.</p>
    <p>
      <bold>M&#233;todos</bold>
    </p>
    <p>
      <bold>Popula&#231;&#227;o do estudo</bold>
    </p>
    <p>Realizou-se um estudo prospectivo de pacientes com SCA sem SST, recrutados no per&#237;odo de 1 de julho de 2004 a 31 de outubro de 2006, desenvolvido em um pronto-socorro. A institui&#231;&#227;o &#233; um centro terci&#225;rio de cardiologia, com uma se&#231;&#227;o de emerg&#234;ncia aberta a atendimentos e interna&#231;&#245;es das mais diversas situa&#231;&#245;es cl&#237;nicas<sup>7</sup>. O Comit&#234; de &#201;tica em Pesquisa local aprovou o protocolo do estudo e todos os pacientes assinaram o Termo de Consentimento Livre e Esclarecido.</p>
    <p>O crit&#233;rio de inclus&#227;o foi o diagn&#243;stico de SCA sem SST com sintomas apresentados dentro das &#250;ltimas 48 horas: dor precordial ou retroesternal descrita como desconforto, aperto ou queima&#231;&#227;o, com dura&#231;&#227;o maior que 10 minutos; dispneia ou s&#237;ncope de prov&#225;vel origem isqu&#234;mica. Os crit&#233;rios de exclus&#227;o foram: infarto agudo do mioc&#225;rdio (IAM) com SST; sintomas de causas n&#227;o card&#237;acas; angina inst&#225;vel secund&#225;ria<sup>8</sup> e altera&#231;&#245;es confundidoras do eletrocardiograma (ECG) (ritmo de marcapasso [MP], ritmo de fibrila&#231;&#227;o atrial [FA], bloqueios de ramo).</p>
    <p>
      <bold>Eletrocardiograma</bold>
    </p>
    <p>As seguintes altera&#231;&#245;es do ECG da admiss&#227;o foram registradas: depress&#227;o do segmento ST <underline>&gt;</underline> 0,5 mil&#237;metros (mm) em, pelo menos, uma deriva&#231;&#227;o eletrocardiogr&#225;fica, medida a 80 milissegundos do ponto J e seguida por segmento ST horizontal ou descendente, utilizando como base o segmento TP precedente; invers&#227;o da onda T <underline>&gt;</underline> 1 mm em duas deriva&#231;&#245;es cont&#237;guas, sendo quantificada pela medida de seu nadir; ondas Q patol&#243;gicas com dura&#231;&#227;o igual ou maior que 0,04 segundos e amplitude maior que um ter&#231;o da amplitude da onda R subsequente, em duas deriva&#231;&#245;es cont&#237;guas.</p>
    <p>
      <bold>Exames laboratoriais</bold>
    </p>
    <p>Amostras de sangue foram coletadas dentro das primeiras 24 horas posteriores &#224; admiss&#227;o dos pacientes. As seguintes vari&#225;veis foram analisadas: hemograma, bioqu&#237;mica, troponina I card&#237;aca (cTnI), fra&#231;&#227;o MB da creatinafosfoquinase (CK-MB) e prote&#237;na C reativa ultrassens&#237;vel (PCR-us). Uma segunda coleta foi realizada 12 horas ap&#243;s a primeira para dosagem da cTnI, CK-MB e PCR-us. Selecionou-se o maior valor da cTnI e da PCR-us entre as duas coletas, sendo as amostras coletadas em tubo seco sem anticoagulante, o qual, ap&#243;s centrifuga&#231;&#227;o imediata, teve o soro conservado em <italic>freezer</italic> a menos 80&#176;C. Foram dosadas pelo m&#233;todo de quimioluminesc&#234;ncia automatizado IMMULITE DPCMedLab. A cTnI foi analisada de forma categ&#243;rica (<underline>&gt;</underline> 0,5 ng/ml), por n&#227;o serem detect&#225;veis valores menores que 0,5 ng/ml ou maiores que 100 ng/ml pela metodologia empregada.</p>
    <p>
      <bold>Desfechos cl&#237;nicos</bold>
    </p>
    <p>O desfecho do estudo foi o composto de morte por todas as causas ou (re)infarto, ocorrendo no per&#237;odo de 30 dias. Dentro das primeiras 24 horas da admiss&#227;o, era considerado o desfecho de (re)infarto se ocorressem sintomas isqu&#234;micos com nova eleva&#231;&#227;o do segmento ST, n&#227;o existente no ECG da admiss&#227;o. Nesse per&#237;odo, a eleva&#231;&#227;o da CK-MB ou da cTnI, sem nova eleva&#231;&#227;o do segmento ST, foi relacionada ao evento da admiss&#227;o. Ap&#243;s 24 horas, o infarto era diagnosticado pela presen&#231;a de novas ondas Q ou novas eleva&#231;&#245;es da CK-MB acima do limite da normalidade, com ou sem altera&#231;&#227;o do ECG. Para pacientes submetidos &#224; interven&#231;&#227;o coronariana percut&#226;nea (ICP) ou &#224; cirurgia de revasculariza&#231;&#227;o mioc&#225;rdica (RM), eleva&#231;&#245;es acima de tr&#234;s ou cinco vezes o limite da normalidade da CK-MB ap&#243;s o procedimento, respectivamente, eram necess&#225;rias para o diagn&#243;stico de infarto relacionado ao procedimento<sup>9</sup>.</p>
    <p>
      <bold>An&#225;lise Estat&#237;stica</bold>
    </p>
    <p>Vari&#225;veis categ&#243;ricas s&#227;o apresentadas por suas distribui&#231;&#245;es de frequ&#234;ncias simples e relativas e as vari&#225;veis cont&#237;nuas por suas m&#233;dias e erros-padr&#227;o. Foi realizada uma an&#225;lise descritiva, complementada por regress&#227;o log&#237;stica simples de vari&#225;veis previamente selecionadas como vari&#225;veis independentes. Vari&#225;veis com n&#237;vel descritivo menor que 10%, tamb&#233;m como sexo, foram selecionadas para a an&#225;lise de regress&#227;o log&#237;stica m&#250;ltipla. Nesta an&#225;lise, empregaram-se os m&#233;todos de <italic>stepwise backward</italic> e <italic>forward</italic> como aux&#237;lio para sele&#231;&#227;o das vari&#225;veis. Vari&#225;veis com <italic>p</italic> &lt; 0,05 foram mantidas no modelo final. A acur&#225;cia preditiva do modelo foi determinada pelo <italic>C statistic</italic><sup>10</sup>. Para o desenvolvimento de um escore pr&#225;tico, atribuiu-se pesos &#224;s vari&#225;veis identificadas, de acordo com as respectivas probabilidades do coeficiente &#946; de regress&#227;o. O escore foi calculado para cada paciente e a popula&#231;&#227;o foi dividida em quatro categorias: muito baixo, baixo, intermedi&#225;rio e alto risco para ocorr&#234;ncia do evento combinado de morte ou (re)infarto em 30 dias.</p>
    <p>O fluxograma do desenho da pesquisa &#233; apresentado na <xref ref-type="fig" rid="f01">Figura 1</xref>.</p>
    <p content-type="asset">
      <fig id="f01">
        <graphic xlink:href="1678-4170-abc-93-04-0343-00006-gf01.jpg"/></fig>
    </p>
    <p>A an&#225;lise estat&#237;stica foi feita por meio do programa SPSS for Windows, vers&#227;o 13.0 (SPSS Institute, Chicago, IIlinois).</p>
    <p>
      <bold>Resultados</bold>
    </p>
    <p>
      <bold>Caracter&#237;sticas dos pacientes, tratamento e evolu&#231;&#227;o</bold>
    </p>
    <p>Foram inclu&#237;dos 1.029 pacientes para compor a popula&#231;&#227;o de desenvolvimento, com perda de seguimento em dois pacientes. Um total de 1.027 pacientes, portanto, correspondeu &#224; popula&#231;&#227;o do estudo. A <xref ref-type="table" rid="t01">Tabela 1</xref> sumariza as caracter&#237;sticas basais da popula&#231;&#227;o estudada. Foram 589 homens (57,4%) e a m&#233;dia de idade de 61,55 anos (&#177; 0,35). O fator de risco para doen&#231;a arterial coronariana (DAC) mais frequente foi hipertens&#227;o arterial sist&#234;mica, seguido de dislipidemia. Na interna&#231;&#227;o, 258 pacientes (25,1%) apresentaram IAM sem SST; 744 (72,4%) revelaram angina inst&#225;vel III B; e 25 (2,4%), angina inst&#225;vel III C da classifica&#231;&#227;o de Braunwald<sup>8</sup>.</p>
    <p content-type="asset">
      <table-wrap id="t01">
        <graphic xlink:href="1678-4170-abc-93-04-0343-00006-gt01.jpg"/></table-wrap>
    </p>
    <p>Os pacientes foram intensamente medicados com betabloqueador (93,0%), &#225;cido acetil salic&#237;lico (97,5%), nitroglicerina endovenosa (94,3%), antitromb&#237;nicos (84,3%), tienopirid&#237;nicos (89,5%), inibidor da enzima conversora da angiotensina (IECA [84,1%]) e estatina (94,4%).</p>
    <p>A cinecoronariografia foi realizada em 734 pacientes (71,5%). Na popula&#231;&#227;o global, a ICP foi indicada a 276 pacientes (26,9%) e a cirurgia de RM em 141 (13,7%). Analisando apenas os pacientes submetidos &#224; cinecoronariografia na atual interna&#231;&#227;o, a indica&#231;&#227;o de ICP ocorreu em 259 casos (35,3%) e a de cirurgia de RM em 114 (15,5%). O procedimento foi realizado durante a interna&#231;&#227;o inicial em 254 (92,0%) e 101 (71,6%) pacientes, respectivamente, para aqueles tratados com ICP e cirurgia de RM.</p>
    <p>Durante a interna&#231;&#227;o, 21 pacientes morreram (2,0%) e 23 (2,2%) sofreram (re)infarto. O desfecho combinado de morte ou (re)infarto em 30 dias ocorreu em 54 pacientes (5,3%).</p>
    <p>
      <bold>An&#225;lise explorat&#243;ria dos dados</bold>
    </p>
    <p>Nos dados da <xref ref-type="table" rid="t01">Tabela 1</xref>, s&#227;o apresentados os resultados da an&#225;lise das vari&#225;veis cl&#237;nicas, eletrocardiogr&#225;ficas e laboratoriais. Diversas vari&#225;veis foram associadas ao risco do evento combinado nesta an&#225;lise.</p>
    <p>
      <bold>An&#225;lise de regress&#227;o log&#237;stica m&#250;ltipla</bold>
    </p>
    <p>Para identificar vari&#225;veis progn&#243;sticas independentes, uma an&#225;lise de regress&#227;o m&#250;ltipla foi realizada com as vari&#225;veis para um n&#237;vel de signific&#226;ncia de 10% na an&#225;lise explorat&#243;ria, mantendo-se o ajuste para o sexo. As seguintes vari&#225;veis n&#227;o mostraram signific&#226;ncia estat&#237;stica na an&#225;lise de regress&#227;o log&#237;stica m&#250;ltipla: sexo; tabagismo atual; angina est&#225;vel pr&#233;via; doen&#231;a arterial perif&#233;rica; DAC <underline>&gt;</underline> 50%; frequ&#234;ncia card&#237;aca; hemat&#243;crito; hemoglobina; leuc&#243;citos totais; PCR-us; e depress&#227;o do segmento ST.</p>
    <p>Apesar de n&#227;o ser estatisticamente significante, a depress&#227;o do segmento ST foi retida no modelo final, em decorr&#234;ncia do seu significado cl&#237;nico, sendo este resultado atribu&#237;do ao problema de multicolinearidade entre a depress&#227;o do segmento ST e a cTnI. As seguintes vari&#225;veis progn&#243;sticas foram identificadas: aumento da idade em anos (<italic>odds ratio</italic> [OR] 1,06; intervalo de confian&#231;a [IC] 95% 1,03 - 1,09; <italic>p</italic> &lt; 0,001); hist&#243;ria pr&#233;via de diabete melito (OR 1,90; IC 95% 1,05 - 3,45; <italic>p</italic> = 0,03); antecedente de acidente vascular cerebral (AVC) (OR 3,46; IC 95% 1,43 - 8,40; <italic>p</italic> = 0,006); utiliza&#231;&#227;o pr&#233;via de IECA (OR 0,57; IC 95% 0,31 - 1,02; <italic>p</italic> = 0,05); eleva&#231;&#227;o da cTnI (OR 2,06; IC 95% 1,12 - 3,78; <italic>p</italic> = 0,01); eleva&#231;&#227;o da creatinina (OR 1,58; IC 95% 1,17 - 2,12; <italic>p</italic> = 0,003); e depress&#227;o do segmento ST (OR 1,54; IC 95% 0,83 - 2,83; <italic>p</italic> = 0,16).</p>
    <p>Para se verificar a ocorr&#234;ncia de multicolinearidade entre a depress&#227;o do segmento ST e a eleva&#231;&#227;o da cTnI, dois modelos de regress&#227;o log&#237;stica m&#250;ltipla foram realizados. Em um deles n&#227;o foi inclu&#237;da a cTnI, cujos resultados foram os seguintes: aumento da idade em anos (OR 1,06; IC 95% 1,03 - 1,09; <italic>p</italic> &lt; 0,001); hist&#243;ria pr&#233;via de diabete melito (OR 1,93; IC 95% 1,07 - 3,49; <italic>p</italic> = 0,02); antecedente de AVC (OR 3,41; IC 95% 1,43 - 8,14; <italic>p</italic> = 0,006); utiliza&#231;&#227;o pr&#233;via de IECA (OR 0,54; IC 95% 0,30 - 0,97; <italic>p</italic> = 0,04); eleva&#231;&#227;o da creatinina (OR 1,65; IC 95% 1,24 - 2,22; <italic>p</italic> = 0,001); e depress&#227;o do segmento ST (OR 1,82; IC 95% 1,01 - 3,28; <italic>p</italic> = 0,04). O outro modelo foi realizado sem a depress&#227;o do segmento ST: aumento da idade em anos (OR 1,06; IC 95% 1,03 - 1,09; <italic>p</italic> &lt; 0,001); hist&#243;ria pr&#233;via de diabete melito (OR 1,95; IC 95% 1,07 - 3,52; <italic>p</italic> = 0,02); antecedente de AVC (OR 3,54; IC 95% 1,46 - 8,58; <italic>p</italic> = 0,005); utiliza&#231;&#227;o pr&#233;via de IECA (OR 0,58; IC 95% 0,32 - 1,04; <italic>p</italic> = 0,07); eleva&#231;&#227;o da cTnI (OR 2,27; IC 95% 1,26 - 4,10; <italic>p</italic> = 0,006); e eleva&#231;&#227;o da creatinina (OR 1,59; IC 95% 1,17 - 2,17; <italic>p</italic> = 0,003). Com a n&#227;o inclus&#227;o da cTnI, a depress&#227;o do segmento ST apresenta-se como vari&#225;vel progn&#243;stica independente para o n&#237;vel de signific&#226;ncia de 5% (OR= 1,82; IC 1,01 - 3,28; <italic>p</italic> = 0,04), sendo mantida no modelo final, no qual a depress&#227;o do segmento ST e a cTnI foram combinadas (<xref ref-type="table" rid="t02">Tabela 2</xref>). O <italic>C statistic</italic> para este modelo foi de 0,78 (IC 0,71 - 0,84; <italic>p</italic> &lt; 0,01), sendo utilizado para o escore de risco Dante Pazzanese.</p>
    <p content-type="asset">
      <table-wrap id="t02">
        <graphic xlink:href="1678-4170-abc-93-04-0343-00006-gt02.jpg"/></table-wrap>
    </p>
    <p>A probabilidade de ocorrer o evento combinado foi calculada para todos os pacientes da popula&#231;&#227;o de desenvolvimento. Para facilitar a utiliza&#231;&#227;o do modelo, sem necessidade de acesso ao computador, foi idealizado um escore com pontua&#231;&#245;es designadas de acordo com as respectivas probabilidades do evento combinado do modelo original. Para o menor valor da probabilidade, foi designado valor igual a 1; para aqueles que eram duas vezes maior, pontua&#231;&#227;o 2; aos que eram tr&#234;s vezes maior, pontua&#231;&#227;o 3 - e assim por diante. Para as vari&#225;veis cont&#237;nuas, foram definidas faixas com valores de probabilidades pr&#243;ximos de uma, duas, tr&#234;s vezes maior e assim por diante. Desenvolveu-se, ent&#227;o, uma escala de pontua&#231;&#227;o que pode variar de 0 a 30 pontos. Ap&#243;s o somat&#243;rio final, o escore para cada paciente seria determinado, podendo o risco do evento combinado ser mostrado por meio de um gr&#225;fico. Na <xref ref-type="fig" rid="f2">Figura 2</xref>, observa-se a representa&#231;&#227;o da pontua&#231;&#227;o do escore de risco Dante Pazzanese e nomograma para probabilidade do desfecho combinado.</p>
    <fig id="f2">
      <graphic xlink:href="1678-4170-abc-93-04-0343-00006-gf02.jpg"/></fig>
    <p>Para cada paciente, foi calculada sua pontua&#231;&#227;o, a fim de avaliar se a escala de pontua&#231;&#227;o mediria a probabilidade do evento combinado na popula&#231;&#227;o de desenvolvimento. Verificou-se a ocorr&#234;ncia de aumento na probabilidade do evento combinado com o aumento gradativo da pontua&#231;&#227;o. Em seguida, os pacientes foram categorizados, conforme a pontua&#231;&#227;o encontrada, em: muito baixo (at&#233; 5 pontos), baixo (6 a 10 pontos), intermedi&#225;rio (11 a 15 pontos) e alto risco (16 a 30 pontos) para o evento de morte ou (re)infarto em at&#233; 30 dias. Houve um progressivo crescimento na propor&#231;&#227;o do evento, com o aumento do escore de risco (<xref ref-type="fig" rid="f3">Figura 3</xref>). A &#225;rea sob a curva <italic>ROC</italic> (<italic>receiver operating characteristic</italic>) do escore de risco foi comparada &#224; &#225;rea sob a curva <italic>ROC</italic> da probabilidade do evento combinado em at&#233; 30 dias (<xref ref-type="fig" rid="f4">Figura 4</xref>). O <italic>C statistic</italic> para a escala de pontua&#231;&#227;o foi de 0,74 (IC 0,67 - 0,81; <italic>p</italic> &lt; 0,001), demonstrando bom desempenho para discriminar quem ter&#225; ou n&#227;o o evento.</p>
    <fig id="f3">
      <graphic xlink:href="1678-4170-abc-93-04-0343-00006-gf03.jpg"/></fig>
    <fig id="f4">
      <graphic xlink:href="1678-4170-abc-93-04-0343-00006-gf04.jpg"/></fig>
    <p>
      <bold>Discuss&#227;o</bold>
    </p>
    <p>O escore de risco Dante Pazzanese foi realizado em um &#250;nico centro de tratamento m&#233;dico, com uma popula&#231;&#227;o demograficamente semelhante. Assim sendo, n&#227;o houve influ&#234;ncia do estilo de vida da popula&#231;&#227;o, da classe social ou da conduta m&#233;dica local. De forma simples, p&#244;de-se determinar a probabilidade para ocorr&#234;ncia de morte ou (re)infarto em 30 dias em pacientes com SCA sem SST. O modelo incorporou vari&#225;veis facilmente coletadas na pr&#225;tica m&#233;dica di&#225;ria: idade; antecedente de diabete melito e AVC; uso de IECA anterior &#224; interna&#231;&#227;o; depress&#227;o do segmento ST no ECG da admiss&#227;o; cTnI; e creatinina.</p>
    <p>Uma popula&#231;&#227;o consecutiva foi avaliada, diferente do que ocorre em modelos de popula&#231;&#245;es de ensaios cl&#237;nicos que acabam por incluir pacientes seletivamente de mais alto risco. O uso de popula&#231;&#245;es selecionadas implica maior probabilidade de perman&#234;ncia no modelo final de vari&#225;veis, as quais fazem parte dos crit&#233;rios de inclus&#227;o da popula&#231;&#227;o do estudo.</p>
    <p>As vari&#225;veis com n&#237;vel descritivo menor que 10% na an&#225;lise explorat&#243;ria foram selecionadas para an&#225;lise de regress&#227;o log&#237;stica m&#250;ltipla, ocorrendo de forma diferente de outros modelos. No modelo de risco <italic>PURSUIT</italic><sup>4</sup> (<italic>Platelet glycoprotein IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin [epitifibatide]</italic>), todas as vari&#225;veis da an&#225;lise univariada foram mantidas no modelo de regress&#227;o log&#237;stica m&#250;ltipla, independente do n&#237;vel de signific&#226;ncia alcan&#231;ado. No escore de risco <italic>TIMI</italic><sup>2</sup> (<italic>Thrombolisis in Myocardial Infarction</italic>), as vari&#225;veis foram selecionadas com n&#237;vel de signific&#226;ncia menor que 20%. No modelo <italic>GRACE</italic><sup>11</sup> (<italic>Global Registry of Acute Coronary Events</italic>), as vari&#225;veis com n&#237;vel de signific&#226;ncia menor que 25% foram selecionadas.</p>
    <p>O avan&#231;ar da idade est&#225; consistentemente associado &#224; ocorr&#234;ncia de eventos adversos em diferentes estudos<sup>2,4,11</sup>. Stone e cols.<sup>12</sup> demonstraram que a idade permaneceu como um fator progn&#243;stico independente de morte, infarto ou isquemia recorrente em seis semanas ap&#243;s um epis&#243;dio de SCA sem SST. No escore de risco Dante Pazzanese, a idade foi mantida no modelo final como vari&#225;vel progn&#243;stica. Foi categorizada em pontos distintos, conforme as probabilidades do evento combinado em cada faixa de pontua&#231;&#227;o, n&#227;o ficando reduzida a um &#250;nico ponto de corte.</p>
    <p>A an&#225;lise isolada dos fatores de risco demonstra que diabete melito &#233; uma vari&#225;vel progn&#243;stica independente, em concord&#226;ncia com relatos pr&#233;vios que a consideram importante fator de risco para morbidade e mortalidade cardiovascular<sup>13</sup>.</p>
    <p>Antecedente de AVC, de ataque isqu&#234;mico transit&#243;rio e de doen&#231;a arterial perif&#233;rica est&#227;o associados &#224; DAC e sua maior extens&#227;o<sup>14,15</sup>. Estas condi&#231;&#245;es cl&#237;nicas afetam negativamente os pacientes com DAC cr&#244;nica<sup>16</sup>. No estudo <italic>OPUS</italic> (<italic>Orbofiban in Patients with Unstable coronary Syndromes</italic>) <italic>TIMI</italic> 16, os investigadores conclu&#237;ram que, nos pacientes com SCA e doen&#231;a vascular extracard&#237;aca, h&#225; associa&#231;&#227;o com DAC mais grave e pior evolu&#231;&#227;o. Possivelmente, esses pacientes receberam tratamento menos agressivo, o que pode explicar, em parte, uma maior ocorr&#234;ncia de desfechos adversos<sup>17</sup>. No escore de risco Dante Pazzanese, AVC pr&#233;vio foi considerado um fator de pior progn&#243;stico, permanecendo no modelo final. Antecedente de doen&#231;a arterial perif&#233;rica demonstrou ser uma vari&#225;vel progn&#243;stica na an&#225;lise explorat&#243;ria, mas n&#227;o na an&#225;lise de regress&#227;o log&#237;stica m&#250;ltipla.</p>
    <p>A utiliza&#231;&#227;o pr&#233;via de IECA foi uma vari&#225;vel preditora de melhor progn&#243;stico, mantendo-se com forte tend&#234;ncia para um resultado favor&#225;vel. Relatos do uso de IECA em pacientes com DAC est&#225;vel, na presen&#231;a de insufici&#234;ncia card&#237;aca e disfun&#231;&#227;o do ventr&#237;culo esquerdo t&#234;m sido publicados<sup>3</sup>. A metan&#225;lise de tr&#234;s importantes estudos<sup>18</sup> demonstra que esta classe de medicamentos reduz, tamb&#233;m, eventos cardiovasculares importantes, em pacientes com aterosclerose e sem evid&#234;ncia de disfun&#231;&#227;o sist&#243;lica do ventr&#237;culo esquerdo ou insufici&#234;ncia card&#237;aca. No escore de risco Dante Pazzanese, identificou-se a n&#227;o administra&#231;&#227;o de IECA anterior &#224; interna&#231;&#227;o como um fator para ocorr&#234;ncia de eventos.</p>
    <p>A utiliza&#231;&#227;o da depress&#227;o do segmento ST <underline>&gt;</underline> 0,5 mm foi baseada em relatos precedentes<sup>19-21</sup>. A depress&#227;o do segmento ST, inicialmente, n&#227;o se apresentou como vari&#225;vel progn&#243;stica para o n&#237;vel de signific&#226;ncia de 5%. Dessa forma, avaliou-se a poss&#237;vel ocorr&#234;ncia de multicolinearidade<sup>22,23</sup> entre a cTnI e a depress&#227;o do segmento ST, por meio da an&#225;lise, em separado, de dois modelos independentes, onde para cada um deles n&#227;o se inclu&#237;a uma dessas vari&#225;veis. A depress&#227;o do segmento ST emerge como vari&#225;vel independente quando a cTnI n&#227;o foi inclu&#237;da no modelo. Em modelos anteriores, o fen&#244;meno pode n&#227;o ter sido observado pelo fato dessas vari&#225;veis serem parte dos crit&#233;rios de inclus&#227;o da popula&#231;&#227;o de desenvolvimento, facilitando sua perman&#234;ncia no modelo final. Neste estudo, optou-se pela inclus&#227;o da combina&#231;&#227;o entre as duas vari&#225;veis, considerando que uma potencializa o efeito da outra.</p>
    <p>Em pacientes com dor tor&#225;cica aguda, n&#237;veis elevados de cTnI nas primeiras 24 horas foram associados ao risco de IAM e de eventos card&#237;acos maiores<sup>24</sup>. Para o escore de risco Dante Pazzanese, a eleva&#231;&#227;o da cTnI foi uma vari&#225;vel independente de pior progn&#243;stico.</p>
    <p>A disfun&#231;&#227;o renal &#233; reconhecida como caracter&#237;stica de alto risco em pacientes com SCA<sup>25</sup>. Surge como vari&#225;vel progn&#243;stica em um dos modelos publicados<sup>11</sup>. No escore de risco Dante Pazzanese, o valor absoluto da creatinina foi uma vari&#225;vel progn&#243;stica independente de pior progn&#243;stico. Para sua melhor aplicabilidade, foi categorizada em faixas de risco. Quanto maior o valor da creatinina, maior ser&#225; a probabilidade de um resultado desfavor&#225;vel.</p>
    <p>O escore de risco Dante Pazzanese apresentou bom desempenho, justificando sua aplicabilidade. Deve ser calculado na admiss&#227;o e atualizado durante a interna&#231;&#227;o, podendo ser empregado para decis&#227;o terap&#234;utica. Deve, como qualquer modelo de estratifica&#231;&#227;o de risco, ser reavaliado futuramente, para a rean&#225;lise das vari&#225;veis existentes, bem como para incorpora&#231;&#227;o de novas vari&#225;veis.</p>
    <p>
      <bold>Limita&#231;&#245;es do estudo</bold>
    </p>
    <p>Este estudo apresenta limita&#231;&#245;es. A cTnI foi avaliada como vari&#225;vel qualitativa. A an&#225;lise quantitativa implicaria avalia&#231;&#227;o do grau de extens&#227;o da necrose mioc&#225;rdica para o risco de eventos adversos. N&#227;o foi realizada a an&#225;lise de ECGs seriados. A an&#225;lise da ocorr&#234;ncia de altera&#231;&#245;es isqu&#234;micas que surgem em outros ECGs que se seguiram ao ECG inicial &#233; uma informa&#231;&#227;o valiosa a ser investigada e que poderia prognosticar poss&#237;veis resultados desfavor&#225;veis. O escore de risco Dante Pazzanese n&#227;o pode ser aplicado a pacientes com altera&#231;&#245;es confundidoras do ECG (ritmo de MP, ritmo de FA, presen&#231;a de bloqueios de ramo); esse grupo de pacientes necessitaria de uma nova an&#225;lise estat&#237;stica para sele&#231;&#227;o das vari&#225;veis progn&#243;sticas espec&#237;ficas.</p>
    <p>
      <bold>Conclus&#227;o</bold>
    </p>
    <p>Um escore simples de estratifica&#231;&#227;o de risco foi desenvolvido em uma popula&#231;&#227;o brasileira com SCA sem SST. &#201; de f&#225;cil execu&#231;&#227;o, com alto valor preditivo para eventos cardiovasculares. Pode ser fonte de informa&#231;&#245;es para a equipe m&#233;dica, para o paciente e seus familiares, englobando importante avalia&#231;&#227;o progn&#243;stica.</p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p>
    <p>
      <bold>Fontes de Financiamento</bold>
    </p>
    <p>O presente estudo n&#227;o teve fontes de financiamento externas.</p>
    <p>
      <bold>Vincula&#231;&#227;o Acad&#234;mica</bold>
    </p>
    <p>Este artigo &#233; parte de tese de Doutorado de Elizabete Silva dos Santos pelo Instituto do Cora&#231;&#227;o (InCor); Hospital das Cl&#237;nicas - Faculdade de Medicina da Universidade de S&#227;o Paulo.</p>
    <p>
      <fn id="back" fn-type="corresp">
        <p>Correspond&#234;ncia:</p>
        <p> Elizabete Silva dos Santos </p>
        <p> Avenida Dr. Dante Pazzanese, n&#250;mero 500 </p>
        <p> 04012-909 - Vila Mariana - S&#227;o Paulo, SP, Brasil </p>
        <p> E-mail: </p>
        <p>
          <email xlink:href="elizabetessantos@cardiol.br">elizabetessantos@cardiol.br</email>
        </p>
      </fn>
    </p>
    <p>Artigo recebido em 25/11/08; revisado recebido em 18/03/09; aceito em 18/03/09</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. Laurenti R,    Buchalla CM, Caratin CVs Doen&#231;a isqu&#234;mica do cora&#231;&#227;o:    interna&#231;&#245;es, tempo de perman&#234;ncia e gastos. Brasil, 1993    a 1997. Arq Bras Cardiol. 2000; 74 (6): 483-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Caratin CVs Doen&#231;a isqu&#234;mica do cora&#231;&#227;o: interna&#231;&#245;es.tempo de perman&#234;ncia e gastos. Brasil, 1993 a 1997</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>483</fpage>
          <lpage>7</lpage>
          <issue>6</issue>
          <volume>74</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Laurenti</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Buchalla</surname>
              <given-names>CM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. Antman EM, Cohen    M, Bernink PJLM, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score    for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic    decision making. JAMA. 2000; 284: 835-42.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making</article-title>
          <source>JAMA</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>835</fpage>
          <lpage>42</lpage>
          <volume>284</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Antman</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bernink</surname>
              <given-names>PJLM</given-names>
            </name>
            <name>
              <surname>McCabe</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Horacek</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Papuchis</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Anderson JL,    Adams CD, Antman EM, Bridges CR, Califf RM, Casey Jr DE, et al. ACC/AHA 2007    Guidelines for the management of patients with unstable angina/non ST-elevation    myocardial infarction: a report of the American College of Cardiology/American    Heart Association Task Force on Practice Guidelines (Writing Committee to Revise    the 2002 Guidelines for the Management of Patients With Unstable Angina/Non    ST-Elevation Myocardial Infarction): developed in collaboration with the American    College of Emergency Physicians, the Society for Cardiovascular Angiography    and Interventions, and the Society of Thoracic Surgeons: endorsed by the American    Association of Cardiovascular and Pulmonary Rehabilitation and the Society for    Academic Emergency Medicine. Circulation. 2007; 116 (7): e148-304.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>ACC/AHA 2007 Guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons</article-title>
          <source>Circulation</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>e148</fpage>
          <lpage>304</lpage>
          <issue>7</issue>
          <volume>116</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Anderson</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Adams</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Antman</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Bridges</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Califf</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Casey Jr</surname>
              <given-names>DE</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Boersma E, Pieper    KS, Steyerberg EW, Wilcox RG, Chang WC, Lee KL, et al. Predictors of outcome    in patients with acute coronary syndromes without persistent ST-segment elevation:    results from an international trial of 9461 patients. The PURSUIT Investigators.    Circulation. 2000; 101: 2557-67.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation: results from an international trial of 9461 patients. The PURSUIT Investigators</article-title>
          <source>Circulation</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>2557</fpage>
          <lpage>67</lpage>
          <volume>101</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Boersma</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Pieper</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Steyerberg</surname>
              <given-names>EW</given-names>
            </name>
            <name>
              <surname>Wilcox</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>KL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Cannon CP. Evidence-based    risk stratification to target therapies in acute coronary syndromes [editorial].    Circulation. 2002; 106: 1588-91.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Evidence-based risk stratification to target therapies in acute coronary syndromes</article-title>
          <source>Circulation</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>1588</fpage>
          <lpage>91</lpage>
          <volume>106</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Cannon</surname>
              <given-names>CP</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Bassand JP,    Hamm CW, Ardissino D, Boersma E, Budaj A, Fern&#225;ndez-Avil&#233;s F,    et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation    acute coronary syndromes. The Task Force for the Diagnosis and Treatment of    Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of    Cardiology. Eur Heart J. 2007; 28: 1598-660.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology</article-title>
          <source>Eur Heart J</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>1598</fpage>
          <lpage>660</lpage>
          <volume>28</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bassand</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Hamm</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Ardissino</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Boersma</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Budaj</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fern&#225;ndez-Avil&#233;s</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. Santos ES, Minuzzo    L, Pereira MP, Castillo MT, Palacio MA, Ramos RF, et al. Registro de s&#237;ndrome    coronariana aguda em um centro de emerg&#234;ncias em cardiologia. Arq Bras    Cardiol. 2006; 87 (5): 597-602.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Registro de s&#237;ndrome coronariana aguda em um centro de emerg&#234;ncias em cardiologia</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>597</fpage>
          <lpage>602</lpage>
          <issue>5</issue>
          <volume>87</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Santos</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Minuzzo</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Pereira</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Castillo</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Palacio</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Ramos</surname>
              <given-names>RF</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Braunwald E.    Unstable angina: a classification. Circulation. 1989; 80: 410-4.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Unstable angina: a classification</article-title>
          <source>Circulation</source>
          <date>
            <year>1989</year>
          </date>
          <fpage>410</fpage>
          <lpage>4</lpage>
          <volume>80</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Braunwald</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Califf RM, Abdelmeguid    AE, Kuntz RE, Popma JJ, Davidson CJ, Cohen EA, et al. Myonecrosis after revascularization    procedures. J Am Coll Cardiol. 1998; 31: 241-51.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Myonecrosis after revascularization procedures</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>241</fpage>
          <lpage>51</lpage>
          <volume>31</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Califf</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Abdelmeguid</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Kuntz</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Popma</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Davidson</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>EA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Harrell Junior    FE, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical    tests. JAMA. 1982; 247: 2543-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Evaluating the yield of medical tests</article-title>
          <source>JAMA</source>
          <date>
            <year>1982</year>
          </date>
          <fpage>2543</fpage>
          <lpage>6</lpage>
          <volume>247</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Harrell Junior</surname>
              <given-names>FE</given-names>
            </name>
            <name>
              <surname>Califf</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Pryor</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Rosati</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Eagle KA, Lim    MJ, Dabbous OH, Pieper KS, Goldberg RJ, Van de Werf F, et al. A validated prediction    model for all forms of acute coronary syndrome: estimating the risk of 6-month    postdischarge death in an international registry. JAMA. 2004; 291: 2727-33.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry</article-title>
          <source>JAMA</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>2727</fpage>
          <lpage>33</lpage>
          <volume>291</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Eagle</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Dabbous</surname>
              <given-names>OH</given-names>
            </name>
            <name>
              <surname>Pieper</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Goldberg</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Van de Werf</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Stone PH, Thompson    B, Anderson HV, Kronenberg MW, Gibson RS, Rogers WJ, et al. Influence of race,    sex, and age on management of unstable angina and non-Q-wave myocardial infarction:    the TIMI III registry. JAMA. 1996; 275: 1104-12.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: the TIMI III registry</article-title>
          <source>JAMA</source>
          <date>
            <year>1996</year>
          </date>
          <fpage>1104</fpage>
          <lpage>12</lpage>
          <volume>275</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Stone</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>HV</given-names>
            </name>
            <name>
              <surname>Kronenberg</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Gibson</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Rogers</surname>
              <given-names>WJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Roffi M, Chew    DP, Mukherjee D, Bhatt DL, White JA, Heeschen C, et al. Platelet glycoprotein    IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation    acute coronary syndromes. Circulation. 2001; 104: 2767-71.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes</article-title>
          <source>Circulation</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>2767</fpage>
          <lpage>71</lpage>
          <volume>104</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Roffi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Chew</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Mukherjee</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bhatt</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Heeschen</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Love BB, Grover-McKay    M, Biller J, Rezai K, McKay CR. Coronary artery disease and cardiac events with    asymptomatic and symptomatic cerebrovascular disease. Stroke. 1992; 23: 939-45.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Coronary artery disease and cardiac events with asymptomatic and symptomatic cerebrovascular disease</article-title>
          <source>Stroke</source>
          <date>
            <year>1992</year>
          </date>
          <fpage>939</fpage>
          <lpage>45</lpage>
          <volume>23</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Love</surname>
              <given-names>BB</given-names>
            </name>
            <name>
              <surname>Grover-McKay</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Biller</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rezai</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>McKay</surname>
              <given-names>CR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. Hirsch AT,    Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et al. Peripheral    arterial disease detection, awareness, and treatment in primary care. JAMA.    2001; 286: 1317-24.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Peripheral arterial disease detection, awareness, and treatment in primary care</article-title>
          <source>JAMA</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>1317</fpage>
          <lpage>24</lpage>
          <volume>286</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hirsch</surname>
              <given-names>AT</given-names>
            </name>
            <name>
              <surname>Criqui</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Treat-Jacobson</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Regensteiner</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Creager</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Olin</surname>
              <given-names>JW</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. Reicher-Reiss    H, Jonas M, Tanne D, Mandelzweig L, Goldbourt U, Shotan A, et al. Prognostic    significance of cerebrovascular disease in 11.526 chronic coronary artery disease    patients. Bezafibrate Infarction Prevention (BIP) Study Group. Am J Cardiol.    1998; 82: 1532-5, A7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prognostic significance of cerebrovascular disease in 11.526 chronic coronary artery disease patients: Bezafibrate Infarction Prevention (BIP)</article-title>
          <source>Study Group. Am J Cardiol</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>1532</fpage>
          <lpage>5, A7</lpage>
          <volume>82</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Reicher-Reiss</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Jonas</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tanne</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Mandelzweig</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Goldbourt</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Shotan</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. Cotter G, Cannon    CP, McCabe CH, Michowitz Y, Kaluski E, Charlesworth A, et al. Prior peripheral    arterial disease and cerebrovascular disease are independent predictors of adverse    outcome in patients with acute coronary syndromes: are we doing enough? Results    from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis    In Myocardial Infarction (OPUS-TIMI) 16 study. Am Heart J. 2003; 145: 622-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study</article-title>
          <source>Am Heart J</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>622</fpage>
          <lpage>7</lpage>
          <volume>145</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Cotter</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Cannon</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>McCabe</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Michowitz</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kaluski</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Charlesworth</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Dagenais GR,    Pogue J, Fox K, Simoons ML, Yusuf S. Angiotensin-converting-enzyme inhibitors    in stable vascular disease without left ventricular systolic dysfunction or    heart failure: a combined analysis of three trials. Lancet. 2006; 368: 581-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials</article-title>
          <source>Lancet</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>581</fpage>
          <lpage>8</lpage>
          <volume>368</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Dagenais</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>Pogue</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Fox</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Simoons</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Yusuf</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19. Cannon CP,    McCabe CH, Stone PH, Rogers WJ, Schactman M, Thompson BW, et al. The electrocardiogram    predicts one-year outcome of patients with unstable angina and non-Q wave myocardial    infarction: results of the TIMI III Registry ECG Ancillary Study. Thrombolysis    in Myocardial Ischemia. J Am Coll Cardiol. 1997; 30: 133-40.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. Thrombolysis in Myocardial Ischemia</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>133</fpage>
          <lpage>40</lpage>
          <volume>30</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Cannon</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>McCabe</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Stone</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Rogers</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Schactman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>BW</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20. Hyde TA, French    JK, Wong CK, Straznicky IT, Whitlock RM, White HD. Four-year survival of patients    with acute coronary syndromes without ST-segment elevation and prognostic significance    of 0.5-mm ST-segment depression. Am J Cardiol. 1999; 84: 379-85.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Four-year survival of patients with acute coronary syndromes without ST-segment elevation and prognostic significance of 0.5-mm ST-segment depression</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>379</fpage>
          <lpage>85</lpage>
          <volume>84</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hyde</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>French</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Straznicky</surname>
              <given-names>IT</given-names>
            </name>
            <name>
              <surname>Whitlock</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>HD</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B21">
        <mixed-citation>21. Savonitto S,    Cohen MG, Politi A, Hudson MP, Kong DF, Huang Y, et al. Extent of ST-segment    depression and cardiac events in non-ST-segment elevation acute coronary syndromes.    Eur Heart J. 2005; 26: 2106-13.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Extent of ST-segment depression and cardiac events in non-ST-segment elevation acute coronary syndromes</article-title>
          <source>Eur Heart J</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>2106</fpage>
          <lpage>13</lpage>
          <volume>26</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Savonitto</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Politi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hudson</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Kong</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <mixed-citation>22. Marill KA.    Advanced statistics: linear regression. Part II: multiple linear regression.    Acad Emerg Med. 2004; 11: 94-102.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Advanced statistics: linear regression. Part II</article-title>
          <source>Acad Emerg Med</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>94</fpage>
          <lpage>102</lpage>
          <volume>11</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Marill</surname>
              <given-names>KA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B23">
        <mixed-citation>23. Slinker BK,    Glantz SA. Multiple linear regression: accounting for multiple simultaneous    determinants of a continuous dependent variable. Circulation. 2008; 117: 1732-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Multiple linear regression: accounting for multiple simultaneous determinants of a continuous dependent variable</article-title>
          <source>Circulation</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>1732</fpage>
          <lpage>7</lpage>
          <volume>117</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Slinker</surname>
              <given-names>BK</given-names>
            </name>
            <name>
              <surname>Glantz</surname>
              <given-names>SA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B24">
        <mixed-citation>24. Polanczyk CA,    Lee TH, Cook EF, Walls R, Wybenga D, Printy-Klein G, et al. Cardiac troponin    I as a predictor of major cardiac events in emergency department patients with    acute chest pain. J Am Coll Cardiol. 1998; 32: 8-14.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiac troponin I as a predictor of major cardiac events in emergency department patients with acute chest pain</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>8</fpage>
          <lpage>14</lpage>
          <volume>32</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Polanczyk</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>TH</given-names>
            </name>
            <name>
              <surname>Cook</surname>
              <given-names>EF</given-names>
            </name>
            <name>
              <surname>Walls</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Wybenga</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Printy-Klein</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <mixed-citation>25. Das M, Aronow    WS, McClung JA, Belkin RN. Increased prevalence of coronary artery disease,    silent myocardial ischemia, complex ventricular arrhythmias, atrial fibrillation,    left ventricular hypertrophy, mitral annular calcium, and aortic valve calcium    in patients with chronic renal insufficiency. Cardiol Rev. 2006; 14: 14-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Increased prevalence of coronary artery disease, silent myocardial ischemia, complex ventricular arrhythmias, atrial fibrillation, left ventricular hypertrophy, mitral annular calcium, and aortic valve calcium in patients with chronic renal insufficiency</article-title>
          <source>Cardiol Rev</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>14</fpage>
          <lpage>7</lpage>
          <volume>14</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Das</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Aronow</surname>
              <given-names>WS</given-names>
            </name>
            <name>
              <surname>McClung</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Belkin</surname>
              <given-names>RN</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRes" xml:lang="es">
    <front-stub>
      <article-categories/>
      <title-group>
        <article-title xml:lang="es">Score de riesgo dante pazzanese para s&#237;ndrome coronario agudo sin supradesnivel del segmento ST</article-title>
      </title-group>
      <abstract xml:lang="es">
        <p>FUNDAMENTO: En el s&#237;ndrome coronario agudo (SCA), es importante estimar la probabilidad de eventos adversos. OBJETIVO: Desarrollar un score de riesgo en una poblaci&#243;n brasile&#241;a con SCA sin supradesnivel del segmento ST (SST). M&#201;TODOS: Se evaluaron prospectivamente 1.027 pacientes en un centro brasile&#241;o de cardiolog&#237;a. Un modelo de regresi&#243;n log&#237;stica m&#250;ltiple se desarroll&#243; para prever el riesgo de muerte o de (re)infarto en 30 d&#237;as. La exactitud predictiva del modelo fue determinada por el C statistic. RESULTADOS: El evento combinado ocurri&#243; en 54 pacientes (5,3%). El score se cre&#243; por la suma aritm&#233;tica de puntos de los predictores independientes, cuyos puntajes se designaron por las respectivas probabilidades de ocurrencia del evento. Se identificaron las siguientes variables: aumento de la edad (0 a 9 puntos); antecedente de diabetes mellitus (2 puntos) o de accidente vascular cerebral (4 puntos); no utilizaci&#243;n previa de inhibidor de la enzima conversora de la angiotensina (1 punto); elevaci&#243;n de la creatinina (0 a 10 puntos); y combinaci&#243;n de elevaci&#243;n de la troponina I card&#237;aca y depresi&#243;n del segmento ST (0 a 4 puntos). Se definieron cuatro grupos de riesgo: muy bajo (at&#233; 5 puntos); bajo (6 a 10 puntos); intermedio (11 a 15 puntos); y alto riesgo (16 a 30 puntos). El C statistic para la probabilidad del evento fue de 0,78 y para el score de riesgo en puntaje de 0,74. CONCLUSI&#211;N: Se desarroll&#243; un score de riesgo para prever muerte o (re)infarto en 30 d&#237;as en una poblaci&#243;n brasile&#241;a con SCA sin SST, pudiendo f&#225;cilmente se aplicable en el departamento de emergencia.</p>
      </abstract>
      <kwd-group xml:lang="es">
        <kwd>Enfermedades cardiovasculares</kwd>
        <kwd>angina inestable</kwd>
        <kwd>infarto de miocardio</kwd>
        <kwd>pron&#243;stico</kwd>
        <kwd>factores de riesgo</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ART&#205;CULO ORIGINAL</bold>
      </p>
      <p>
        <fn id="top-body2">
          <label>
            <bold>Score de riesgo dante pazzanese para s&#237;ndrome coronario agudo sin supradesnivel del segmento ST</bold>
          </label>
          <p>
            <bold>Elizabete Silva dos Santos<sup>I, II</sup>; Ari Timerman<sup>II</sup>; Val&#233;ria Troncoso Baltar<sup>II</sup>; Maria Tereza Cabrera Castillo<sup>II</sup>; Marcos Paulo Pereira<sup>II</sup>; Luiz Minuzzo<sup>II</sup>; Leopoldo Soares Piegas<sup>II</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Instituto do Cora&#231;&#227;o (InCor) HC-FMUSP</p>
      <p><sup>II</sup>Instituto Dante Pazzanese de Cardiologia, S&#227;o Paulo, SP, Brasil</p>
      <p>Correspond&#234;ncia</p>
      <p>
        <bold>RESUMEN</bold>
      </p>
      <p><bold>FUNDAMENTO: </bold> En el s&#237;ndrome coronario agudo (SCA), es importante estimar la probabilidad de eventos adversos.</p>
      <p><bold>OBJETIVO: </bold> Desarrollar un score de riesgo en una poblaci&#243;n brasile&#241;a con SCA sin supradesnivel del segmento ST (SST).</p>
      <p><bold>M&#201;TODOS: </bold> Se evaluaron prospectivamente 1.027 pacientes en un centro brasile&#241;o de cardiolog&#237;a. Un modelo de regresi&#243;n log&#237;stica m&#250;ltiple se desarroll&#243; para prever el riesgo de muerte o de (re)infarto en 30 d&#237;as. La exactitud predictiva del modelo fue determinada por el C statistic.</p>
      <p><bold>RESULTADOS: </bold> El evento combinado ocurri&#243; en 54 pacientes (5,3%). El score se cre&#243; por la suma aritm&#233;tica de puntos de los predictores independientes, cuyos puntajes se designaron por las respectivas probabilidades de ocurrencia del evento. Se identificaron las siguientes variables: aumento de la edad (0 a 9 puntos); antecedente de diabetes mellitus (2 puntos) o de accidente vascular cerebral (4 puntos); no utilizaci&#243;n previa de inhibidor de la enzima conversora de la angiotensina (1 punto); elevaci&#243;n de la creatinina (0 a 10 puntos); y combinaci&#243;n de elevaci&#243;n de la troponina I card&#237;aca y depresi&#243;n del segmento ST (0 a 4 puntos). Se definieron cuatro grupos de riesgo: muy bajo (at&#233; 5 puntos); bajo (6 a 10 puntos); intermedio (11 a 15 puntos); y alto riesgo (16 a 30 puntos). El C <italic>statistic</italic> para la probabilidad del evento fue de 0,78 y para el score de riesgo en puntaje de 0,74.</p>
      <p><bold>CONCLUSI&#211;N: </bold> Se desarroll&#243; un score de riesgo para prever muerte o (re)infarto en 30 d&#237;as en una poblaci&#243;n brasile&#241;a con SCA sin SST, pudiendo f&#225;cilmente se aplicable en el departamento de emergencia.</p>
      <p><bold>Palabras clave: </bold> Enfermedades cardiovasculares, angina inestable, infarto de miocardio, pron&#243;stico, factores de riesgo.</p>
      <p>
        <bold>Introducci&#243;n</bold>
      </p>
      <p>Las enfermedades cardiovasculares representan la primera causa de muerte no s&#243;lo en los pa&#237;ses desarrollados, sino tambi&#233;n en los en desarrollo<sup>1</sup>.</p>
      <p>El riesgo de &#243;bito o de eventos isqu&#233;micos recurrentes entre pacientes con s&#237;ndrome coronario agudo (SCA) sin supradesnivel del segmento ST (SST) var&#237;a ampliamente debido a su naturaleza heterog&#233;nea. Determinar el riesgo de ocurrencia de estos eventos es importante para la evaluaci&#243;n inicial en el departamento de emergencia, donde se identificar&#225;n los pacientes que se benefician con conductas m&#225;s agresivas, costos y de mayor morbilidad y mortalidad<sup>2</sup>. Es importante determinar tal riesgo para que se seleccione el local m&#225;s apropiado para la realizaci&#243;n de los cuidados m&#233;dicos y en la indicaci&#243;n de la estrategia invasiva precoz<sup>3</sup>. La decisi&#243;n de cual terapia utilizar para cada paciente depende de la presentaci&#243;n cl&#237;nica y de los beneficios alcanzados con el tratamiento instituido<sup>4</sup>, los cuales deben compensar los riesgos de resultados adversos.</p>
      <p>La estrategia para estratificaci&#243;n de riesgo apunta a una evaluaci&#243;n de variables que pueda prever resultados adversos al momento del ingreso en el departamento de emergencia<sup>5</sup>. Debe basarse en la combinaci&#243;n de la historia cl&#237;nica, s&#237;ntomas presentados, alteraciones electrocardiogr&#225;ficas, biomarcadores plasm&#225;ticos y resultados de los scores de riesgo<sup>6</sup>.</p>
      <p>El objetivo de esta investigaci&#243;n fue desarrollar un modelo simple de estratificaci&#243;n de riesgo, f&#225;cilmente aplicable en el departamento de emergencia, en una poblaci&#243;n brasile&#241;a no seleccionada, con el uso de variables cl&#237;nicas, electrocardiogr&#225;ficas y biomarcadores plasm&#225;ticos.</p>
      <p>
        <bold>M&#233;todos</bold>
      </p>
      <p>
        <bold>Poblaci&#243;n del estudio</bold>
      </p>
      <p>Se realiz&#243; un estudio prospectivo de pacientes con SCA sin SST, reclutados en el per&#237;odo de 1&#186; de julio de 2004 a 31 de octubre de 2006, desarrollado en un servicio de emergencia. La instituci&#243;n es un centro terciario de cardiolog&#237;a, con una secci&#243;n de emergencia abierta a consultas e internaciones de las m&#225;s diversas situaciones cl&#237;nicas<sup>7</sup>. El Comit&#233; de &#201;tica en Investigaci&#243;n local aprob&#243; el protocolo de estudio y todos los pacientes firmaron el T&#233;rmino de Consentimiento Libre e Informado.</p>
      <p>El criterio de inclusi&#243;n fue el diagn&#243;stico de SCA sin SST con s&#237;ntomas presentados dentro de las &#250;ltimas 48 horas: dolor precordial o retroesternal descrita como incomodidad, opresi&#243;n o ardor con duraci&#243;n superior a 10 minutos. Los criterios de exclusi&#243;n fueron: infarto agudo de miocardio (IAM) con SST; s&#237;ntomas de causas no card&#237;acas; angina inestable secundaria<sup>8</sup>; y alteraciones confundidoras del electrocardiograma (ECG) (ritmo de marcapasos [MP], ritmo de fibrilaci&#243;n atrial [FA], bloqueos de rama).</p>
      <p>
        <bold>Electrocardiograma</bold>
      </p>
      <p>Se registraron las siguientes alteraciones del ECG del ingreso: depresi&#243;n del segmento ST <underline>&gt;</underline> 0,5 mil&#237;metros (mm) en por lo menos una derivaci&#243;n electrocardiogr&#225;fica, medida a 80 milissegundos del punto J y seguida por segmento ST horizontal o descendente, utilizando como base el segmento TP precedente; inversi&#243;n de la onda T <underline>&gt;</underline> 1 mm en dos derivaciones contiguas, siendo cuantificada por la medida de su nadir; ondas Q patol&#243;gicas con duraci&#243;n igual o mayor que 0,04 segundos y amplitud mayor que un tercio de la amplitud de la onda R subsiguiente, en dos derivaciones contiguas.</p>
      <p>
        <bold>Ex&#225;menes de laboratorio</bold>
      </p>
      <p>Se recogieron muestras de sangre dentro de las primeras 24 horas posteriores al ingreso de los pacientes. Se analizaron las siguientes variables: hemograma, bioqu&#237;mica, troponina I card&#237;aca (cTnI), fracci&#243;n MB de la creatina fosfoquinasa (CK-MB) y prote&#237;na C reactiva ultrasensible (PCR-us). Se realiz&#243; una segunda recolecci&#243;n 12 horas despu&#233;s de la primera para determinaci&#243;n de cTnI, CK-MB y PCR-us. Se seleccion&#243; el mayor valor de la cTnI y de la PCR-us entre las dos extracciones, las muestras se recogieron en tubo seco sin anticoagulante y despu&#233;s de centrifugaci&#243;n inmediata, se conserv&#243; el suero en <italic>freezer</italic> a menos 80&#176;C. Se analizaron por el m&#233;todo de quimioluminiscencia automatizado IMMULITE DPCMedLab. La cTnI se analiz&#243; de forma categ&#243;rica (<underline>&gt;</underline> 0,5 ng/ml), por no ser detectables valores inferiores a 0,5 ng/ml o superiores a 100 ng/ml por la metodolog&#237;a empleada.</p>
      <p>
        <bold>Desenlaces cl&#237;nicos</bold>
      </p>
      <p>El desenlace del estudio estuvo compuesto por muerte por todas las causas o (re)infarto, ocurridos en el per&#237;odo de 30 d&#237;as. Dentro de las primeras 24 horas del ingreso, se consideraba el desenlace de (re)infarto si se presentaban s&#237;ntomas isqu&#233;micos con nueva elevaci&#243;n del segmento ST no existente en el ECG del ingreso. En ese per&#237;odo, la elevaci&#243;n de la CK-MB o de la cTnI, sin nueva elevaci&#243;n del segmento ST, se relacion&#243; con el evento del ingreso. Despu&#233;s de 24 horas, el infarto era diagnosticado por la presencia de nuevas ondas Q o nuevas elevaciones de la CK-MB por encima del l&#237;mite de la normalidad, con o sin alteraci&#243;n del ECG. Para pacientes sometidos a intervenci&#243;n coronaria percut&#225;nea (ICP) o a la cirug&#237;a de revascularizaci&#243;n mioc&#225;rdica (RM), elevaciones superiores a tres o cinco veces el l&#237;mite de la normalidad de la CK-MB despu&#233;s del procedimiento, respectivamente, eran necesarias para el diagn&#243;stico de infarto relacionado al procedimiento<sup>9</sup>.</p>
      <p>
        <bold>An&#225;lisis estad&#237;stico</bold>
      </p>
      <p>Variables categ&#243;ricas se presentan por sus distribuciones de frecuencias simples y relativas, y las variables continuas por sus promedios y errores est&#225;ndar. Se realiz&#243; un an&#225;lisis descriptivo, complementado por regresi&#243;n log&#237;stica simple de variables previamente seleccionadas como variables independientes. Variables con nivel descriptivo inferior al 10%, tambi&#233;n como sexo, se seleccionaron para el an&#225;lisis de regresi&#243;n log&#237;stica m&#250;ltiple. En este an&#225;lisis, se emplearon los m&#233;todos de <italic>stepwise backward</italic> y <italic>forward</italic> como auxilio para la selecci&#243;n de las variables. Variables con <italic>p</italic> &lt; 0,05 se mantuvieron en el modelo final. La exactitud predictiva del modelo fue determinada por el <italic>C statistic</italic><sup>10</sup>. Para el desarrollo de un score pr&#225;ctico, se atribuyeron pesos a las variables identificadas, de acuerdo con las respectivas probabilidades del coeficiente &#946; de regresi&#243;n. El score se calcul&#243; para cada paciente y la poblaci&#243;n se dividi&#243; en cuatro categor&#237;as: muy bajo, bajo, intermedio y alto riesgo para ocurrencia del evento combinado de muerte o (re)infarto en 30 d&#237;as.</p>
      <p>El flujograma del dise&#241;o de la investigaci&#243;n se presenta en la <xref ref-type="fig" rid="f1-body2">Figura 1</xref>.</p>
      <p content-type="asset">
        <fig id="f1-body2">
          <graphic xlink:href=""/>
        </fig>
      </p>
      <p>El an&#225;lisis estad&#237;stico se realiz&#243; por medio del programa SPSS for Windows, versi&#243;n 13.0 (SPSS Institute, Chicago, IIlinois).</p>
      <p>
        <bold>Resultados</bold>
      </p>
      <p>
        <bold>Caracter&#237;sticas de los pacientes, tratamiento y evoluci&#243;n</bold>
      </p>
      <p>Se incluyeron 1.029 pacientes para componer la poblaci&#243;n de desarrollo, con p&#233;rdida de seguimiento en dos pacientes. Un total de 1.027 pacientes, por lo tanto, correspondi&#243; a la poblaci&#243;n del estudio. La <xref ref-type="table" rid="t1-body2">Tabla 1</xref> resume las caracter&#237;sticas basales de la poblaci&#243;n estudiada. Eran 589 hombres (57,4%) y el promedio de edad de 61,55 a&#241;os (&#177; 0,35). El factor de riesgo para enfermedad arterial coronaria (EAC) m&#225;s frecuente fue hipertensi&#243;n arterial sist&#233;mica, seguido de dislipidemia. En la internaci&#243;n, 258 pacientes (25,1%) presentaron IAM sin SST; 744 (72,4%) revelaron angina inestable III B; e 25 (2,4%), angina inestable III C de la clasificaci&#243;n de Braunwald<sup>8</sup>.</p>
      <p content-type="asset">
        <table-wrap id="t1-body2">
          <graphic xlink:href=""/>
        </table-wrap>
      </p>
      <p>Los pacientes fueron intensamente medicados con betabloqueador (93,0%), &#225;cido acetil salic&#237;lico (97,5%), nitroglicerina endovenosa (94,3%), antitromb&#237;nicos (84,3%), tienopirid&#237;nicos (89,5%), inhibidor de la enzima conversora de la angiotensina (IECA [84,1%]) y estatina (94,4%).</p>
      <p>La cinecoronariograf&#237;a se realiz&#243; en 734 pacientes (71,5%). En la poblaci&#243;n global, la ICP se indic&#243; a 276 pacientes (26,9%) y la cirug&#237;a de RM a 141 (13,7%). Analizando s&#243;lo los pacientes sometidos a la cinecoronariograf&#237;a en la actual internaci&#243;n, la indicaci&#243;n de ICP ocurri&#243; en 259 casos (35,3%) y la de cirug&#237;a de RM en 114 (15,5%). El procedimiento se realiz&#243; durante la internaci&#243;n inicial en 254 (92,0%) y 101 (71,6%) pacientes, respectivamente, para aquellos tratados con ICP y cirug&#237;a de RM.</p>
      <p>Durante la internaci&#243;n, 21 pacientes fallecieron (2,0%) y 23 (2,2%) sufrieron (re)infarto. El desenlace combinado de muerte o (re)infarto en 30 d&#237;as ocurri&#243; en 54 pacientes (5,3%).</p>
      <p>
        <bold>An&#225;lisis exploratorio de los datos</bold>
      </p>
      <p>En los datos de la <xref ref-type="table" rid="t1-body2">Tabla 1</xref>, se presentan los resultados del an&#225;lisis de las variables cl&#237;nicas, electrocardiogr&#225;ficas y anal&#237;ticas. Diversas variables se asociaron al riesgo de evento combinado en este an&#225;lisis.</p>
      <p>
        <bold>An&#225;lisis de regresi&#243;n log&#237;stica m&#250;ltiple</bold>
      </p>
      <p>Para identificar variables pron&#243;sticas independientes, se realiz&#243; un an&#225;lisis de regresi&#243;n m&#250;ltiple con las variables para un nivel de significancia del 10% en el an&#225;lisis exploratorio, manteni&#233;ndose el ajuste para el sexo. Las siguientes variables no mostraron significancia estad&#237;stica en el an&#225;lisis de regresi&#243;n log&#237;stica m&#250;ltiple: sexo; tabaquismo actual; angina estable previa; enfermedad arterial perif&#233;rica; EAC <underline>&gt;</underline> 50%; frecuencia card&#237;aca; hematocrito; hemoglobina; leucocitos totales; PCR-us; y depresi&#243;n del segmento ST.</p>
      <p>A pesar de no ser estad&#237;sticamente significativa, la depresi&#243;n del segmento ST se retuvo en el modelo final, en raz&#243;n de su significado cl&#237;nico, siendo este resultado atribuido al problema de multicolinealidad entre la depresi&#243;n del segmento ST y la cTnI. Se identificaron las siguientes variables pron&#243;sticas: aumento de la edad en a&#241;os (<italic>odds ratio</italic> [OR] 1,06; intervalo de confianza [IC] 95% 1,03 - 1,09; <italic>p</italic> &lt; 0,001); historia previa de diabetes mellitus (OR 1,90; IC 95% 1,05 - 3,45; <italic>p</italic> = 0,03); antecedente de Accidente vascular cerebral (AVC) (OR 3,46; IC 95% 1,43 - 8,40; <italic>p</italic> = 0,006); uso previo de IECA (OR 0,57; IC 95% 0,31 - 1,02; <italic>p</italic> = 0,05); elevaci&#243;n de la cTnI (OR 2,06; IC 95% 1,12 - 3,78; <italic>p</italic> = 0,01); elevaci&#243;n de la creatinina (OR 1,58; IC 95% 1,17 - 2,12; <italic>p</italic> = 0,003); y depresi&#243;n del segmento ST (OR 1,54; IC 95% 0,83 - 2,83; <italic>p</italic> = 0,16).</p>
      <p>Para verificar la ocurrencia de multicolinealidad entre la depresi&#243;n del segmento ST y la elevaci&#243;n de la cTnI, se realizaron dos modelos de regresi&#243;n log&#237;stica m&#250;ltiple. En uno de ellos no se incluy&#243; la cTnI, cuyos resultados fueron los siguientes: aumento de la edad en a&#241;os (OR 1,06; IC 95% 1,03 - 1,09; <italic>p</italic> &lt; 0,001); historia previa de diabetes mellitus (OR 1,93; IC 95% 1,07 - 3,49; <italic>p</italic> = 0,02); antecedente de AVC (OR 3,41; IC 95% 1,43 - 8,14; <italic>p</italic> = 0,006); uso previo de IECA (OR 0,54; IC 95% 0,30 - 0,97; <italic>p</italic> = 0,04); elevaci&#243;n de la creatinina (OR 1,65; IC 95% 1,24 - 2,22; <italic>p</italic> = 0,001); y depresi&#243;n del segmento ST (OR 1,82; IC 95% 1,01 - 3,28; <italic>p</italic> = 0,04). El otro modelo se realiz&#243; sin la depresi&#243;n del segmento ST: aumento de la edad en a&#241;os (OR 1,06; IC 95% 1,03 - 1,09; <italic>p</italic> &lt; 0,001); historia previa de diabetes mellitus (OR 1,95; IC 95% 1,07 - 3,52; <italic>p</italic> = 0,02); antecedente de AVC (OR 3,54; IC 95% 1,46 - 8,58; <italic>p</italic> = 0,005); uso previo de IECA (OR 0,58; IC 95% 0,32 - 1,04; <italic>p</italic> = 0,07); elevaci&#243;n de la cTnI (OR 2,27; IC 95% 1,26 - 4,10; <italic>p</italic> = 0,006); y elevaci&#243;n de la creatinina (OR 1,59; IC 95% 1,17 - 2,17; <italic>p</italic> = 0,003). Con la inclusi&#243;n de la cTnI, la depresi&#243;n del segmento ST se presenta como variable pron&#243;stica independiente para el nivel de significancia del 5% (OR= 1,82; IC 1,01 - 3,28; <italic>p</italic> = 0,04), siendo mantenida en el modelo final, en el cual la depresi&#243;n del segmento ST y la cTnI fueron combinadas (<xref ref-type="table" rid="t2-body2">Tabla 2</xref>). El <italic>C statistic</italic> para este modelo fue de 0,78 (IC 0,71 - 0,84; <italic>p</italic> &lt; 0,01), siendo utilizado para el score de riesgo Dante Pazzanese.</p>
      <p content-type="asset">
        <table-wrap id="t2-body2">
          <graphic xlink:href=""/>
        </table-wrap>
      </p>
      <p>La probabilidad de ocurrir el evento combinado se calcul&#243; para todos los pacientes de la poblaci&#243;n en desarrollo. Para facilitar la utilizaci&#243;n del modelo, sin necesidad de acceso al ordenador, se idealiz&#243; un score con puntajes designados de acuerdo con las respectivas probabilidades del evento combinado del modelo original. Para el menor valor de probabilidad, se design&#243; valor igual a 1; para aquellos que eran dos veces mayor, puntaje 2; a los que eran tres veces mayor, puntaje 3 - y as&#237; sucesivamente. Para las variables continuas se definieron intervalos con valores de probabilidades pr&#243;ximos a una, dos, tres veces mayor y as&#237; sucesivamente. Se desarroll&#243; entonces una escala de puntaje que puede variar de 0 a 30 puntos. Despu&#233;s de la sumatoria final, el score para cada paciente ser&#237;a determinado, pudiendo mostrar el riesgo del evento combinado por medio de un gr&#225;fico. En la <xref ref-type="fig" rid="f2-body2">Figura 2</xref> se observa la representaci&#243;n del puntaje del score de riesgo Dante Pazzanese y nomograma para probabilidad de desenlace combinado.</p>
      <fig id="f2-body2">
        <graphic xlink:href=""/>
      </fig>
      <p>Para cada paciente se calcul&#243; su puntaje, a fin de evaluar si la escala de puntaje medir&#237;a la probabilidad del evento combinado en la poblaci&#243;n de desarrollo. Se verific&#243; la ocurrencia de aumento en la probabilidad del evento combinado con el aumento gradual del puntaje. A seguir, los pacientes fueron categorizados seg&#250;n el puntaje encontrado, en: muy bajo (at&#233; 5 puntos); bajo (6 a 10 puntos); intermedio (11 a 15 puntos); y alto riesgo (16 a 30 puntos) para el evento de muerte o (re)infarto en hasta 30 d&#237;as. Hubo un progresivo crecimiento en la proporci&#243;n del evento, con el aumento del score de riesgo (<xref ref-type="fig" rid="f3-body2">Figura 3</xref>). El &#225;rea bajo la curva <italic>ROC</italic> (<italic>receiver operating characteristic</italic>) del score de riesgo se compar&#243; con el &#225;rea bajo la curva <italic>ROC</italic> de la probabilidad del evento combinado en hasta 30 d&#237;as (<xref ref-type="fig" rid="f4-body2">Figura 4</xref>). El <italic>C statistic</italic> para la escala de puntaje fue de 0,74 (IC 0,67 - 0,81; <italic>p</italic> &lt; 0,001), demostrando buen desempe&#241;o para discriminar quien presentar&#225; o no el evento.</p>
      <fig id="f3-body2">
        <graphic xlink:href=""/>
      </fig>
      <fig id="f4-body2">
        <graphic xlink:href=""/>
      </fig>
      <p>
        <bold>Discusi&#243;n</bold>
      </p>
      <p>El score de riesgo Dante Pazzanese se realiz&#243; en un &#250;nico centro de tratamiento m&#233;dico, con una poblaci&#243;n demogr&#225;ficamente similar. Siendo as&#237;, no hubo diferencia en el estilo de vida de la poblaci&#243;n, de la clase social o de la conducta m&#233;dica local. De forma simple, se pudo determinar la probabilidad para ocurrencia de muerte o (re)infarto en 30 d&#237;as en pacientes con SCA sin SST. El modelo incorpor&#243; variables f&#225;cilmente recolectadas en la pr&#225;ctica m&#233;dica diaria: edad; antecedente de diabetes mellitus y AVC; uso de IECA anterior a la internaci&#243;n; depresi&#243;n del segmento ST en el ECG del ingreso; cTnI; y creatinina.</p>
      <p>Se evalu&#243; una poblaci&#243;n consecutiva, diferente de lo que ocurre en modelos de poblaciones de ensayos cl&#237;nicos que terminan por incluir pacientes selectivamente de m&#225;s alto riesgo. El uso de poblaciones seleccionadas implica mayor probabilidad de permanencia en el modelo final de variables, las cuales forman parte de los criterios de inclusi&#243;n de la poblaci&#243;n del estudio.</p>
      <p>Las variables con nivel descriptivo menor que el 10% en el an&#225;lisis exploratorio se seleccionaron para an&#225;lisis de regresi&#243;n log&#237;stica m&#250;ltiple, ocurriendo de forma diferente de otros modelos. En el modelo de riesgo <italic>PURSUIT</italic><sup>4</sup> (<italic>Platelet glycoprotein IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin [epitifibatide]</italic>), todas las variables de an&#225;lisis univariado se mantuvieron en el modelo de regresi&#243;n log&#237;stica m&#250;ltiple, independiente del nivel de significancia alcanzado. En el score de riesgo <italic>TIMI</italic><sup>2</sup> (<italic>Thrombolisis in Myocardial Infarction</italic>), las variables fueron seleccionadas con nivel de significancia menor que el 20%. En el modelo <italic>GRACE</italic><sup>11</sup> (<italic>Global Registry of Acute Coronary Events</italic>), se seleccionaron las variables con nivel de significancia menor que el 25%.</p>
      <p>El avanzar de la edad est&#225; consistentemente asociado a la ocurrencia de eventos adversos en diferentes estudios<sup>2,4,11</sup>. Stone et al. <sup>12</sup> demostraron que la edad permaneci&#243; como un factor pron&#243;stico independiente de muerte, infarto o isquemia recurrente en seis semanas despu&#233;s de un episodio de SCA sin SST. En el score de riesgo Dante Pazzanese, la edad se mantuvo en el modelo final como variable pron&#243;stica. Se categoriz&#243; en puntos distintos, conforme las probabilidades del evento combinado en cada intervalo de puntaje, sin quedar reducida a un &#250;nico punto de corte.</p>
      <p>El an&#225;lisis aislado de los factores de riesgo demuestra que la diabetes mellitus es una variable pron&#243;stica independiente, en concordancia con relatos previos que la consideran importante factores de riesgo para morbilidad y mortalidad cardiovascular<sup>13</sup>.</p>
      <p>Antecedente de AVC, de ataque isqu&#233;mico transitorio y de Enfermedad arterial perif&#233;rica est&#225;n asociados a la EAC y su mayor extensi&#243;n<sup>14,15</sup>. Estas condiciones cl&#237;nicas afectan negativamente a los pacientes con EAC cr&#243;nica<sup>16</sup>. En el estudio <italic>OPUS</italic> (<italic>Orbofiban in Patients with Unstable coronary Syndromes</italic>) <italic>TIMI</italic> 16, los investigadores concluyeron que, en los pacientes con SCA y enfermedad vascular extracard&#237;aca, hay asociaci&#243;n con EAC m&#225;s grave y peor evoluci&#243;n. Posiblemente, estos pacientes recibieron tratamiento menos agresivo, lo que puede explicar en parte una mayor ocurrencia de desenlaces adversos<sup>17</sup>. En el score de riesgo Dante Pazzanese, AVC previo fue considerado un factor de peor pron&#243;stico, permaneciendo en el modelo final. Antecedente de enfermedad arterial perif&#233;rica demostr&#243; ser una variable pron&#243;stica en el an&#225;lisis exploratorio, pero no en el an&#225;lisis de regresi&#243;n log&#237;stica m&#250;ltiple.</p>
      <p>La utilizaci&#243;n previa de IECA fue una variable predictora de mejor pron&#243;stico, manteni&#233;ndose con fuerte tendencia para un resultado favorable. Fueron publicados relatos de uso de IECA en pacientes con EAC estable, en presencia de insuficiencia card&#237;aca y disfunci&#243;n del ventr&#237;culo izquierdo<sup>3</sup>. El metaan&#225;lisis de tres importantes estudios<sup>18</sup> demuestra que esta clase de medicamentos reduce tambi&#233;n eventos cardiovasculares importantes, en pacientes con aterosclerosis y sin evidencia de disfunci&#243;n sist&#243;lica del ventr&#237;culo izquierdo o insuficiencia card&#237;aca. En el score de riesgo Dante Pazzanese se identific&#243; la no administraci&#243;n de IECA anterior a la internaci&#243;n como un factor para ocurrencia de eventos.</p>
      <p>La utilizaci&#243;n de la depresi&#243;n del segmento ST <underline>&gt;</underline> 0,5 mm se bas&#243; en relatos precedentes<sup>19-21</sup>. La depresi&#243;n del segmento ST, inicialmente, no se present&#243; como variable pron&#243;stica para el nivel de significancia del 5%. De esta forma se evalu&#243; la posible ocurrencia de multicolinealidad<sup>22,23</sup> entre la cTnI y la depresi&#243;n del segmento ST, por medio del an&#225;lisis, en separado, de dos modelos independientes, en que para cada uno de ellos no se inclu&#237;a una de esas variables. La depresi&#243;n del segmento ST surge como variable independiente cuando la cTnI no fue incluida en el modelo. En modelos anteriores, el fen&#243;meno puede no haber sido observado por el hecho de esas variables formar parte de los criterios de inclusi&#243;n de la poblaci&#243;n de desarrollo, facilitando su permanencia en el modelo final. En este estudio se opt&#243; por la inclusi&#243;n de la combinaci&#243;n entre las dos variables, considerando que una potencializa el efecto de la otra.</p>
      <p>En pacientes con dolor tor&#225;cico agudo, niveles elevados de cTnI en las primeras 24 horas fueron asociados al riesgo de IAM y de eventos card&#237;acos mayores<sup>24</sup>. Para el score de riesgo Dante Pazzanese, la elevaci&#243;n de la cTnI fue una variable independiente de peor pron&#243;stico.</p>
      <p>La disfunci&#243;n renal es reconocida como caracter&#237;stica de alto riesgo en pacientes con SCA<sup>25</sup>. Surge como variable pron&#243;stica en uno de los modelos publicados<sup>11</sup>. En el score de riesgo Dante Pazzanese, el valor absoluto de la creatinina fue una variable pron&#243;stica independiente de peor pron&#243;stico. Para su mejor aplicabilidad, se categoriz&#243; en intervalos de riesgo. Cuando mayor el valor de la creatinina, mayor ser&#225; la probabilidad de un resultado desfavorable.</p>
      <p>El score de riesgo Dante Pazzanese present&#243; buen desempe&#241;o, justificando su aplicabilidad. Debe ser calculado al ingreso y actualizado durante la internaci&#243;n, pudiendo ser empleado para decisi&#243;n terap&#233;utica. Como cualquier modelo de estratificaci&#243;n de riesgo debe ser reevaluado futuramente, para el rean&#225;lisis de las variables existentes as&#237; como para incorporaci&#243;n de nuevas variables.</p>
      <p>
        <bold>Limitaciones del estudio</bold>
      </p>
      <p>Este estudio presenta limitaciones. La cTnI fue evaluada como variable cualitativa. El an&#225;lisis cuantitativo implicar&#237;a evaluaci&#243;n del grado de extensi&#243;n de la necrosis mioc&#225;rdica para el riesgo de eventos adversos. No se realiz&#243; el an&#225;lisis de ECG seriados. El an&#225;lisis de la ocurrencia de alteraciones isqu&#233;micas que surgen en otros ECG que siguieron al ECG inicial es una informaci&#243;n valiosa a ser investigada y que podr&#237;a pronosticar posibles resultados desfavorables. El score de riesgo Dante Pazzanese no puede ser aplicado a pacientes con alteraciones confundidoras del ECG (ritmo de MP, ritmo de FA, presencia de bloqueos de rama); este grupo de pacientes necesitar&#237;a un nuevo an&#225;lisis estad&#237;stico para selecci&#243;n de las variables pron&#243;sticas espec&#237;ficas.</p>
      <p>
        <bold>Conclusi&#243;n</bold>
      </p>
      <p>Se desarroll&#243; un score simple de estratificaci&#243;n de riesgo en una poblaci&#243;n brasile&#241;a con SCA sin SST. Es de f&#225;cil ejecuci&#243;n, con alto valor predictivo para eventos cardiovasculares. Puede ser fuente de informaciones para el equipo m&#233;dico, para el paciente y sus familiares, englobando importante evaluaci&#243;n pron&#243;stica.</p>
      <p>
        <bold>Potencial Conflicto de Intereses</bold>
      </p>
      <p>Declaro no haber conflicto de intereses pertinentes.</p>
      <p>
        <bold>Fuentes de Financiaci&#243;n</bold>
      </p>
      <p>El presente estudio no tuvo fuentes de financiaci&#243;n externas.</p>
      <p>
        <bold>Vinculaci&#243;n Acad&#233;mica</bold>
      </p>
      <p>Este art&#237;culo forma parte de tesis de Doctorado de Elizabete Silva dos Santos del Instituto del Coraz&#243;n (InCor); Hospital das Cl&#237;nicas - Facultad de Medicina de la Universidad de S&#227;o Paulo.</p>
      <p>
        <bold>Referencias</bold>
      </p>
    </body>
  </sub-article>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Dante Pazzanese risk score for non-st-segment elevation acute coronary syndrome</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>BACKGROUND: The probability of adverse events estimate is crucial in acute coronary syndrome condition. OBJECTIVES: To develop a risk score for the brazilian population presenting non-ST-segment elevation acute coronary syndrome. METHODS: One thousand and twenty seven (1,027) patients were investigated prospectively at a cardiology center in Brazil. A multiple logistic regression model was developed to estimate death or (re)infarction risk within 30 days. Model predictive accuracy was determined by C statistic. RESULTS: Combined event occurred in 54 patients (5.3%). The score was created by the arithmetic sum of independent predictors points. Points were determined by corresponding probabilities of event occurrence. The following variables have been identified: age increase (0 to 9 points); diabetes mellitus history (2 points) or prior stroke (4 points); no previous use of angiotensin converting enzyme inhibitor (1 point); creatinine level increase (0 to 10 points); the combination of troponin I level increase and ST-segment depression (0 to 4 points). Four risk groups were defined: very low (up to 5 points); low (6 to 10 points ); intermediate (11 to 15 points ); high risk (16 to 30 points ). The C statistic was 0.78 for event probability, and 0.74 for risk score. CONCLUSION: A risk score of easy application in the emergency service was developed to predict death or (re)infarction within 30 days in a brazilian population with non-ST-segment elevation acute coronary syndrome.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Cardiovascular diseases</kwd>
        <kwd>unstable angina</kwd>
        <kwd>myocardial infarction</kwd>
        <kwd>prognostic</kwd>
        <kwd>risk factors</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ORIGINAL ARTICLE</bold>
      </p>
      <p>
        <fn id="top-body3">
          <label>
            <bold>Dante pazzanese risk score for Non-ST-Segment elevation acute coronary syndrome</bold>
          </label>
          <p>
            <bold>Elizabete Silva dos Santos<sup>I, II</sup>; Ari Timerman<sup>II</sup>; Val&#233;ria Troncoso Baltar<sup>II</sup>; Maria Tereza Cabrera Castillo<sup>II</sup>; Marcos Paulo Pereira<sup>II</sup>; Luiz Minuzzo<sup>II</sup>; Leopoldo Soares Piegas<sup>II</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Instituto do Cora&#231;&#227;o (InCor) HC-FMUSP</p>
      <p><sup> II</sup>Instituto Dante Pazzanese de Cardiologia, S&#227;o Paulo, SP, Brasil</p>
      <p>Mailing Address</p>
      <p>
        <bold>SUMMARY</bold>
      </p>
      <p><bold>BACKGROUND: </bold> The probability of adverse events estimate is crucial in acute coronary syndrome condition.</p>
      <p><bold>OBJECTIVES:</bold> To develop a risk score for the brazilian population presenting non-ST-segment elevation acute coronary syndrome.</p>
      <p><bold>METHODS:</bold> One thousand and twenty seven (1,027) patients were investigated prospectively at a cardiology center in Brazil. A multiple logistic regression model was developed to estimate death or (re)infarction risk within 30 days. Model predictive accuracy was determined by C statistic.</p>
      <p><bold>RESULTS:</bold> Combined event occurred in 54 patients (5.3%). The score was created by the arithmetic sum of independent predictors points. Points were determined by corresponding probabilities of event occurrence. The following variables have been identified: age increase (0 to 9 points); diabetes mellitus history (2 points) or prior stroke (4 points); no previous use of angiotensin converting enzyme inhibitor (1 point); creatinine level increase (0 to 10 points); the combination of troponin I level increase and ST-segment depression (0 to 4 points). Four risk groups were defined: very low (up to 5 points); low (6 to 10 points ); intermediate (11 to 15 points ); high risk (16 to 30 points ). The C statistic was 0.78 for event probability, and 0.74 for risk score.</p>
      <p><bold>CONCLUSION:</bold> A risk score of easy application in the emergency service was developed to predict death or (re)infarction within 30 days in a brazilian population with non-ST-segment elevation acute coronary syndrome.</p>
      <p><bold>Key Words:</bold> Cardiovascular diseases; unstable angina; myocardial infarction; prognostic; risk factors.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>Cardiovascular diseases are the first cause of death not only in developed countries but in developing countries as well<sup>1</sup>.</p>
      <p>The risk of death or of recurrent ischemic events among patients with non-ST-segment elevation acute coronary syndrome varies widely due to heterogeneity. Therefore, it is important that the risk of experiencing these adverse events be determined for initial screening at the emergency department, as well as for identifying those patients who may benefit from potent but expensive and sometimes risky new therapies<sup>2</sup>. It is also crucial when choosing the most appropriate location for medical care and the recommendation of early invasive strategy<sup>3</sup>. The decision on the therapy to be used for each patient depends on their clinical presentation as well as the benefits from treatment choice<sup>4</sup>, which is to deliver benefits that make up for the risks from adverse results.</p>
      <p>The strategy for risk stratification aims at assessing the variables that may predict adverse results at the point in time when patients are being screened at the emergency unit<sup>5</sup> and must be based on the combination of patient's clinical history, symptoms, electrocardiographic changes, plasma biomarkers, and risk score results<sup>6</sup>.</p>
      <p>Study objective was to develop a risk stratification model that would be simple, and of easy application at the emergency unit for a brazilian population that had not gone through a selection, and using clinical, electrocardiographic variables as well as plasma biomarkers.</p>
      <p>
        <bold>Methods</bold>
      </p>
      <p>
        <italic>
          <bold>Study Population</bold>
        </italic>
      </p>
      <p>This was a prospective study of non-ST-segment elevation acute coronary syndrome patients, recruited in the period between July 1, 2004 and October 31, 2006, and developed at the emergency unit. The institution is a tertiary cardiology center, with an emergency unit open to medical assistance and hospital admittance for a wide variety of clinical conditions<sup>7</sup>. Study Protocol was approved by the local Research Ethics Committee. All patients signed the Informed Consent Form.</p>
      <p>The inclusion criterion was having been diagnosed with non-ST-segment elevation acute coronary syndrome, with symptoms having been presented in the previous 48 hours: precordial or restrosternal pain described as chest discomfort, tightness or burning for a period longer than 10 minutes or dyspnea or syncope that might be ischemic in origin. Exclusion criteria included: ST-segment elevation acute myocardial infarction; non-cardiac causes symptoms; secondary unstable angina<sup>8</sup>; confounding electrocardiographic changes (pacemaker pace, atrial fibrillation rhythm, bundled branch block).</p>
      <p>
        <italic>
          <bold>Electrocardiogram (ECG)</bold>
        </italic>
      </p>
      <p>The following electrocardiographic changes were recorded at admittance: ST-segment depression <underline>&gt;</underline> 0.5 mm in at least one electrocardiographic lead measured at 80 milliseconds from J point followed by horizontal or descending ST-segment based on previous TP segment; inversion of T wave <underline>&gt;</underline> 1 mm in two contiguous leads, quantified by nadir measurement; pathologic Q waves that are 0.04 seconds long or longer, and amplitude larger than 1/3 of subsequent R wave in two contiguous leads.</p>
      <p>
        <italic>
          <bold>Laboratory Exams</bold>
        </italic>
      </p>
      <p>Blood samples were collected within 24 hours after admission. The following variables have been identified: hemogram, biochemistry, cardiac troponin I (cTnI), creatinaphosphokinase MB fraction (CK-MB) and high sensitivity C-reactive protein (hs-CRP). A second sample was collected 12 hours after the first for cTnI, CK-MB and hs - CRP level. The higher level of cTnI and hs - CRP was taken from the two samples. The samples were collected in dry vials with no anticoagulant added. Ater immediate centrifugation serum was kept in the freezer at - 80&#176; C. Biomarkers level measure was done through IMMULITE DPCMedLab automated chemiluminiscence. Categorical data analysis was used for cTnI (<underline>&gt;</underline> 0.5 ng/ml), since no values under 0.5 ng/ml or higher than 100 ng/ml were detectable through the methodology being used.</p>
      <p>
        <italic>
          <bold>Clinical Outcome</bold>
        </italic>
      </p>
      <p>Study outcomes included death due to all causes or (re)infarction within 30 days. (Re)infarction was considered as the clinical outcome whenever ischemic symptoms with new ST-segment elevation not shown on ECG at admission occurred within the first 24 hours from admission. In that period of time, either CK-MB or cTnI level increase with no new ST-segment elevation was related to admission event. After 24 hours, infarction was diagnosed by the presence of new Q waves or new CK-MB increases above normal level with or without ECG changes. For patients who had been submitted to percutaneous coronary interventions (PCI) or to coronary artery bypass graft (CABG) surgery, elevations that were respectively three or five times higher than CK-MB normal values were necessary for the diagnosis of procedure-related infarction<sup>9</sup>.</p>
      <p>
        <italic>
          <bold>Statistical Analysis</bold>
        </italic>
      </p>
      <p>Categorical variables are presented through simple and relative distribution frequencies; continuous variables, through means and standard errors. A descriptive analysis was performed, and complemented by simple logistic regression of variables previously selected as independent variables. Variables with descriptive level &lt; 10 %, as well as gender, were selected for multiple logistic regression analysis. Stepwise backward and forward methods were used to help the selection of variables. Variables presenting <italic>p</italic> &lt; 0.05 were kept in the final model. Predictive accuracy of the model was determined by the use of C statistic<sup>10</sup>. In order to develop a practical score, identified variables were given different weights according to respective probabilities of &#946; regression coefficient. The score was calculated for each patient. The population was divided into four categories: very low, low, intermediate, and high risk for the occurrence of the combination of death or (re)infarction within 30 days.</p>
      <p>Research design flowchart can be found in <xref ref-type="fig" rid="en_06f01-body3">Figure 1</xref>.</p>
      <p content-type="asset">
        <fig id="en_06f01-body3">
          <graphic xlink:href="1678-4170-abc-93-04-0343-00006-gf01-en.jpg"/></fig>
      </p>
      <p>Statistical analysis was carried out using SPSS for Windows, Version 13.0 (SPSS Institute, Chicago, IIlinois).</p>
      <p>
        <bold>Results</bold>
      </p>
      <p>
        <italic>
          <bold>Patients' Characteristics, Treatment and Course</bold>
        </italic>
      </p>
      <p>One thousand and twenty nine (1,029) patients were included in the study population. Two patients were lost to follow-up. Therefore, study population included a total of one thousand and twenty-seven (1,027) patients. <xref ref-type="table" rid="en_06t01-body3">Table 1</xref> shows a summary of study population baseline characteristics. Five hundred and eighty-nine were males (57.4%), and mean age was 61.55 years of age (&#177; 0.35). Most frequent risk factor for coronary artery disease (CAD) was systemic arterial hypertension followed by dyslipidemia. At admission, 258 patients (25.1%) presented non-ST-segment elevation acute myocardial infarction; 744 (72.4%) presented unstable angina III B; and 25 (2.4%), unstable angina III C in Braunwald's classification<sup>8</sup>.</p>
      <p content-type="asset">
        <table-wrap id="en_06t01-body3">
          <graphic xlink:href="1678-4170-abc-93-04-0343-00006-gt01-en.jpg"/></table-wrap>
      </p>
      <p>Patients were intensely medicated with betablocker (93.0%), salicylic acetyl acid (97.5%), IV nitroglycerin (94.3%), antithrombinics (84.3%), tienopiridinics (89.5%), angiotensin converting enzyme inhibitors (ACEI [84.1%]) and statin (94.4%).</p>
      <p>Cinecoronariography was performed in 734 patients (71.5%). In the population as a whole, PCI was the indication for 276 patients (26.9%), and CABG surgery for 141 (13.7%). When analyzing only the patients who had been submitted to cinecoronariography in the ongoing hospitalization, PCI was indicated for 259 of them (35.3%), and CABG surgery for 114 (15.5%). The procedure was performed in the first in-hospital period in 254 patients (92%) and for 101 patients (71.6%) respectively for those treated with PCI and CABG surgery.</p>
      <p>Twenty-one patients died in hospital (2.0%) and 23 (2.2%) had (re)infarction. The combined outcome - death or (re)infarction within 30 days - was reported for 54 patients (5.3%).</p>
      <p>
        <italic>
          <bold>Data Exploratory Analysis</bold>
        </italic>
      </p>
      <p><xref ref-type="table" rid="en_06t01-body3">Table 1</xref> shows data on the results of exploratory analysis of clinical, electrocardiographic and laboratory variables. Many of the variables were associated to the risk of the combined outcome in this analysis.</p>
      <p>
        <italic>
          <bold>Multiple Logistic Regression Analysis</bold>
        </italic>
      </p>
      <p>In order to identify independent prognostic variables, a multiple regression analysis was performed with variables for a 10% significance level in the exploratory analysis. Gender adjustment was kept in the analysis. The variables that follow have not shown statistic significance in the multiple logistic regression analysis: gender; current smoking habit; previous stable angina; peripheral artery disease; CAD <underline>&gt;</underline> 50%; heart rate; hematocrit; hemoglobin; total leukocyte count; hs - CRP; and ST-segment depression.</p>
      <p>Although not statistically significant, ST-segment depression was kept in the final model due to its clinical significance. That was seen as the result of the multicollinearity between ST-segment depression and cTnI. The following prognostic variables have been identified: increased age (odds ratio [OR] 1.06; confidence interval [CI 95% 1.03 - 1.09; <italic>p</italic> &lt; 0.001); previous history of diabetes mellitus (OR 1.90; CI 95% 1.05 - 3.45; <italic>p</italic> = 0.03); prior stroke (OR 3.46; CI 95% 1.43 - 8.40; <italic>p</italic> = 0.006); previous use of ACEI (OR 0.57; CI 95% 0.31 - 1.02; <italic>p</italic> = 0.05); elevation of cTnI (OR 2.06; CI 95% 1.12 - 3.78; <italic>p</italic> = 0.01); elevation of creatinine (OR 1.58; CI 95% 1.17 - 2.12; <italic>p</italic> = 0.003); ST-segment depression (OR 1.54; CI 95% 0.83 - 2.83; <italic>p</italic> = 0.16).</p>
      <p>In order to verify the occurrence of multicollinearity between ST-segment depression and elevation of cTnI two multiple logistic regression models were performed. In one of them cTnI was not included. The results were the following: increased age (OR 1.06; CI 95% 1.03 -1.09; <italic>p</italic> &lt; 0.001); previous history of diabetes mellitus (OR 1.93; CI 95% 1.07 - 3.49; <italic>p</italic> = 0.02); prior stroke (OR 3.41; CI 95% 1.43 - 8.14; <italic>p</italic> = 0.006); previous use of ACEI (OR 0.54; CI 95% 0.30 - 0.97; <italic>p</italic> = 0.04); elevation of creatinine (OR 1.65; CI 95% 1.24 - 2.22; <italic>p</italic> = 0.001); ST-segment depression (OR 1.82; CI 95% 1.01 - 3.28; <italic>p</italic> = 0.04). The other model was performed without ST-segment depression: increased age (OR 1.06; CI 95% 1.03 - 1.09; <italic>p</italic> &lt; 0.001); previous history of diabetes mellitus (OR 1.95; CI 95% 1.07 - 3.52; <italic>p</italic> = 0.02); prior stroke (OR 3.54; CI 95% 1.46 - 8.58; <italic>p</italic> = 0.005); previous use of ACEI (OR 0.58; CI 95% 0.32 - 1.04; <italic>p</italic> = 0.07); elevation of cTnI (OR 2.27; CI 95% 1.26 - 4.10; <italic>p</italic> = 0.006); elevation of creatinine (OR 1.59; CI 95% 1.17 - 2.17; <italic>p</italic> = 0.003). With cTnI not having been included, ST-segment depression was presented as an independent prognostic variable for 5% significance level (OR= 1.82; CI 1.01 - 3.28; <italic>p</italic> = 0.04), having been kept in the final model where ST-segment depression and cTnI were combined (<xref ref-type="table" rid="en_06t02-body3">Table 2</xref>). The C-statistic for this model was 0.78 (CI 0.71-0.84; <italic>p</italic> &lt; 0.01), and therefore was used in the Dante Pazzanese Risk Score.</p>
      <p content-type="asset">
        <table-wrap id="en_06t02-body3">
          <graphic xlink:href="1678-4170-abc-93-04-0343-00006-gt02-en.jpg"/></table-wrap>
      </p>
      <p>The probability for the occurrence of a combined event was calculated for all patients in the population under study. For easier use of the model without the need of a computer, a score was created with points assigned according to the corresponding probabilities for the combined event in the original model. The lowest probability value was assigned to be = 1; values that were twice as high = 2, and those three times as high = 3, and so on. For continuous variables ranges were determined with values close to same height, twice as high, three times as high, and so on. A point scale was then developed varying from 0 to 30 points. After the final summing up, a score was calculated for each patient. Combined event risk was shown in a graphic. <xref ref-type="fig" rid="f2-body3">Figure 2</xref> shows Dante Pazzanese risk score points and probability nomogram for combined outcome.</p>
      <fig id="f2-body3">
        <graphic xlink:href="1678-4170-abc-93-04-0343-00006-gf02-en.jpg"/></fig>
      <p>The score of each patient was calculated to assess the effectiveness of the scoring scale in predicting the probability of composite endpoint in the population studied. Combined event probability was observed to increase as scale points increased. Patients were then ranked following the number of points: very low (up to 5 points); low (6 to 10 points); intermediate (11 to 15 points); high risk (16 to 30 points) for death or (re)infarction within 30 days. The event increased progressively as score risk increased (<xref ref-type="fig" rid="f3-body3">Figure 3</xref>). The area under the ROC (receiver operating characteristic) curve of risk score was compared to the area under the ROC curve of combined event probability within 30 days (<xref ref-type="fig" rid="f4-body3">Figure 4</xref>). The C statistic for the point scale was 0.74 (CI 0.67 - 0.81; <italic>p</italic> &lt; 0.001), which showed good performance to discriminate those who will present the event and those who will not.</p>
      <fig id="f3-body3">
        <graphic xlink:href="1678-4170-abc-93-04-0343-00006-gf03-en.jpg"/></fig>
      <fig id="f4-body3">
        <graphic xlink:href="1678-4170-abc-93-04-0343-00006-gf04-en.jpg"/></fig>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>The Dante Pazzanese risk score was applied in a single center to a population sharing similar demographic characteristics. Consequently, there was no influence from the study population lifestyle and social class or from the local clinical practice. It was a very simple way to determine the probability for the occurrence of death or (re)infarction within 30 days in patients with non-ST segment elevation acute coronary syndrome. The model incorporated variables that are easily obtained from daily medical practice: age; history of diabetes mellitus and stroke; use of ACEI prior to hospital admission; ST-segment depression shown in ECG at admission; cTnI; creatinine level.</p>
      <p>Unlike other clinical trials that select patients at higher risk, our population was enrolled consecutively. The use of selected populations implies higher probability of permanence in the final model of the variables that are part of the study population inclusion criteria.</p>
      <p>Variables with descriptive level &lt; 10 % in the exploratory analysis were selected for multiple logistic regression analysis. That approach differred from the other models. In the PURSUIT<sup>4</sup> risk model all univariate analysis variables were kept in the multiple logistic regression model, irrespective of significance level. In TIMI<sup>2</sup> risk score variables were selected with significance level &lt; 20%. In GRACE<sup>11</sup> risk score variables were selected with significance level &lt; 25%.</p>
      <p>Advanced age showed to be constantly associated to adverse events in a number of studies<sup>2,4,11</sup>. Stone et al<sup>12</sup> have demonstrated that age has remained an independent prognosis factor for death, infarction or recurrent ischemia within six weeks after an episode of non-ST-segment elevation acute coronary syndrome. In the Dante Pazzanese risk score age was kept in the final model as prognostic variable. It was accounted for through distinctive points in regard to the probabilities of the combined event for each point range, and never narrowed down to one sole cutt-off point.</p>
      <p>The isolated analysis of risk factors showed that diabetes mellitus is an independend prognostic variable, which was consistent with previous reports ranking it as a key risk factor for cardiovascular morbidity and mortality<sup>13</sup>.</p>
      <p>A history of stroke, transient ischemic attack and peripheral artery disease are associated to CAD and its wider-reaching extension<sup>14,15</sup>. Those clinical conditions affect chronic CAD patients negatively<sup>16</sup>. In the OPUS TIMI 16 study, investigators concluded that patients with both acute coronary syndrome and extracardiac vascular disease show an association with more severe CAD and worse outcomes. Those patients have probably received less aggressive treatment, which partially explains the higher occurrence of adverse outcomes<sup>17</sup>. In the Dante Pazzanese risk score, previous stroke was considered a factor for worse prognosis, having been kept in the final model. A history of peripheral artery disease was shown to be a prognostic variable in the exploratory analysis but not in the multiple logistic regression analysis.</p>
      <p>Previous use of ACEI was a predictive variable for better prognosis, strongly pointing towards favorable results. Reports on the use of ACEI by patients with stable CAD under heart failure condition and left ventricle dysfunction have been published elsewhere<sup>3</sup>. Metanalysis from three prestigious studies<sup>18</sup> has demonstrated that this drug class also reduces major cardiovascular events in atherosclerotic patients with no evidence of left ventricle systolic dysfunction or heart failure. The Dante Pazzanese risk score identified non-administration of ACEI prior to hospital admission as a factor for event occurrence.</p>
      <p>The use of ST-segment depression <underline>&gt;</underline> 0.5mm was based on previous reports<sup>19-21</sup>. At a first moment, ST-segment depression was not observed to be a prognostic variable at 5% significance level. That allowed the assessment of the possibility of multicollinearity<sup>22,23</sup> between cTnI and ST-segment depression, through a separate analysis of two independent models - those variables were not included in one of them. ST-segment depression emerges as an independent variable when cTnI is not included in the model. The phenomenon may not have been observed in previous models due to the fact that those variables are part of the inclusion criteria for the study population, thus making it easier to keep them in the final model. In the present study the authors chose to include the combination between the two variables, considering that one potentializes the effect of the other.</p>
      <p>In patients under acute chest pain, high levels of cTnI within the first 24 hours have been associated to the risk for acute myocardial infarction and of major cardiac events<sup>24</sup>. In the Dante Pazzanese risk score, cTnI increase showed to be an independent variable for worse prognosis.</p>
      <p>Renal dysfunction is recognized as high risk for acute coronary syndrome patients<sup>25</sup>. It has proven to be a prognostic variable in one of the models published<sup>11</sup>. In the Dante Pazzanese risk score the absolute value of creatinine accummulation was an independent prognostic variable for worse prognosis. For better applicability, it was categorized in risk ranges. The higher creatinine accummulation the higher the probability of unfavorable results.</p>
      <p>The Dante Pazzanese risk score reported good performance, thus justifying its applicability. It should be calculated at hospital admission and updated during hospital stay. It may be used for therapeutic decision-making. As any other risk stratification model, it should be subject to future reassessment, so that existing variables can be re-analyzed and new variables may be incorporated.</p>
      <p>
        <bold>Study Limitations</bold>
      </p>
      <p>The present study presents some limitations. The cTnI was assessed as qualitative variable. Quantitative analysis would imply an assessment of myocardial necrosis extension for the risk of adverse events. Serial ECG recordings were not obtained. The analysis of ischemic changes that may occur in other ECG recordings after the baseline ECG provides valuable data to be investigated and that could predict potentially unfavorable outcomes. The Dante Pazzanese risk score should not be applied to patients with changes confounding the ECG pattern (pacemaker rhythm, atrial fibrillation rhythm, bundled branch block). This group of patients would need new statistical analysis for the selection of specific prognostic variables.</p>
      <p>
        <bold>Conclusion</bold>
      </p>
      <p>An easy-to use risk stratification score was developed in a brazilian population with non-ST-segment elevation acute coronary syndrome. Easily applicable, it holds high predictive value for cardiovascular events. It may serve as source of information for medical teams, and for patients and their famliers as relevant prognostic assessment.</p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>Sources of Funding</bold>
      </p>
      <p>There were no external funding sources for this study.</p>
      <p>
        <bold>Study Association</bold>
      </p>
      <p>This article is part of the thesis of doctoral submitted by Elizabete Silva dos Santos, from Instituto do Cora&#231;&#227;o (InCor); Hospital das Cl&#237;nicas - Faculdade de Medicina da Universidade de S&#227;o Paulo.</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
</article>
